Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Open accessAbstract
The lifespan of people with severe mental illness (SMI) is shorter compared to the general population. This excess mortality is mainly due to physical illness. We report prevalence rates of different physical illnesses as well as important individual lifestyle choices, side effects of psychotropic treatment and disparities in health care access, utilization and provision that contribute to these poor physical health outcomes. We searched MEDLINE (1966 - August 2010) combining the MeSH terms of schizophrenia, bipolar disorder and major depressive disorder with the different MeSH terms of general physical disease categories to select pertinent reviews and additional relevant studies through cross-referencing to identify prevalence figures and factors contributing to the excess morbidity and mortality rates. Nutritional and metabolic diseases, cardiovascular diseases, viral diseases, respiratory tract diseases, musculoskeletal diseases, sexual dysfunction, pregnancy complications, stomatognathic diseases, and possibly obesity-related cancers are, compared to the general population, more prevalent among people with SMI. It seems that lifestyle as well as treatment specific factors account for much of the increased risk for most of these physical diseases. Moreover, there is sufficient evidence that people with SMI are less likely to receive standard levels of care for most of these diseases. Lifestyle factors, relatively easy to measure, are barely considered for screening; baseline testing of numerous important physical parameters is insufficiently performed. Besides modifiable lifestyle factors and side effects of psychotropic medications, access to and quality of health care remains to be improved for individuals with SMI.
AI snapshot
Written from the paper’s full text.
TL;DR
People with severe mental illness (SMI) have substantially elevated physical morbidity and mortality, with excess mortality two to three times that of the general population and a 13–30 year shortened life expectancy. This selective review reports higher prevalence of obesity, metabolic syndrome, diabetes, cardiovascular disease, viral infections, respiratory disease, osteoporosis, sexual dysfunction, pregnancy complications, and oral disease in SMI, alongside medication effects and health care disparities.
Key findings
- Excess mortality in SMI is two or three times as high as in the general population, translating to a 13–30 year shortened life expectancy; about 60% of this excess mortality is due to physical illness.
- Obesity is more common in SMI: people with schizophrenia have a 2.8–3.5 increased likelihood of being obese, with reported obesity rates of 42–60%; those with major depression or bipolar disorder have a 1.2–1.5 increased likelihood.
- Metabolic syndrome is highly prevalent in treated schizophrenia, with estimates between 19.4% and 68%; rates in bipolar disorder and schizoaffective disorder are reported as 22–30% and 42%, respectively. Diabetes prevalence is 2–3 fold higher in schizophrenia, bipolar disorder, and schizoaffective disorder, and 1.2–2.6 times higher with depression or depressive symptoms.
- Health care disparities are marked: baseline metabolic testing rates for patients starting novel antipsychotics vary between 8% and less than 30%, with follow-up assessments in only 8.8%; in CATIE, non-treatment rate for diabetes was 45.3%, and up to 88% of schizophrenia patients had untreated dyslipidemia and up to 62% untreated hypertension.
Methods
- Selective, rather than systematic, review of clinical data on physical health problems in people with SMI.
- Searched MEDLINE (1966–August 2010) combining MeSH terms for schizophrenia, bipolar disorder, and major depressive disorder with MeSH terms for major general physical disease categories; included pertinent reviews and cross-referenced additional relevant studies, sometimes using specific physical illnesses as search terms.
- Aimed to identify prevalence figures and factors contributing to excess morbidity and mortality, including lifestyle, psychotropic medication effects, and disparities in health care access, utilization, and provision.
Limitations
- Stated: the review is selective rather than systematic and did not include all physical diseases.
- Stated: there is a paucity of information and a lack of large, well-designed, prospective comparative studies during pregnancy; data on antidepressant-associated diabetes risk are sparse; cancer findings in SMI are conflicting.
- Evident: prevalence estimates vary widely by metabolic syndrome criteria, country or region, gender, ethnicity, age group, and antipsychotic treatment, limiting any single summary figure.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 259 cited sources checked · 0 supported · 0 flagged
- Findingcitation
People with schizophrenia exhibit a higher metabolic syndrome prevalence than their peers in the general population across the world.
“people with schizophrenia exhibit a higher MetS prevalence than their peers in the general population across the world”
Quote in the paperNot a substantial claim - Findingcitation
Most children starting treatment with novel antipsychotics do not receive recommended glucose and lipid screening.
“most children starting treatment with novel AP do not receive recommended glucose and lipid screening”
Quote in the paperNot a substantial claim - Findingcitation
The metabolic syndrome is highly prevalent among treated patients with schizophrenia.
“The MetS is highly prevalent among treated patients with schizophrenia”
Quote in the paperNot a substantial claim - Findingnone given§ WPA EDUCATIONAL MODULE
People with severe mental illness are less likely to receive standard levels of care for most physical diseases.
“there is sufficient evidence that people with SMI are less likely to receive standard levels of care for most of these diseases”
Quote in the paperSubstantial claim - Findingcitation
In patients with severe mental illness, obesity is associated with lifestyle factors, illness-related factors, and treatment-related factors including weight liability of certain psychotropic agents.
“In patients with SMI, as in the general population, obesity is associated with lifestyle factors (e.g., lack of exercise, poor diet), but also with illness-related (negative, disorganized and depressive symptoms) and treatment-related factors, including weight liability of certain psychotropic agents”
Quote in the paperNot a substantial claim
- Findingnone given
After FDA and ADA/APA recommendations for novel antipsychotics, the frequency of baseline glucose and lipid testing showed little change.
“Even after FDA (Food and Drug Administration) and ADA (American Diabetes Association)/APA (American Psychiatric Association) recommendations for novel AP, the frequency of baseline glucose and lipid testing showed little change”
Quote in the paperNot a substantial claim - Findingreasoning§ WPA EDUCATIONAL MODULE
Lifestyle and treatment-specific factors account for much of the increased risk for most physical diseases in severe mental illness.
“It seems that lifestyle as well as treatment specific factors account for much of the increased risk for most of these physical diseases”
Quote in the paperSubstantial claim - Findingnone given§ WPA EDUCATIONAL MODULE
Lifestyle factors are barely considered for screening in severe mental illness.
“Lifestyle factors, relatively easy to measure, are barely considered for screening”
Quote in the paperNot a substantial claim - Findingcitation
The risk of obesity in persons with severe mental illness varies by diagnosis.
“The risk of obesity in persons with SMI, however, varies by diagnosis”
Quote in the paperNot a substantial claim - Findingcitation
The proportion of severe mental illness patients not receiving tests for assessing metabolic risk factors, even for obesity and blood pressure, is high.
“The proportion of SMI patients not receiving tests for assessing metabolic risk factors, even for factors relatively simple and easy to measure, such as obesity and blood pressure, is high”
Quote in the paperSubstantial claim - Findingcitation
Evidence suggests that the prevalence of diabetes mellitus in people with schizophrenia as well as in people with bipolar disorder and schizoaffective disorder is 2-3 fold higher compared with the general population.
“Evidence suggests that the prevalence of DM in people with schizophrenia as well as in people with bipolar disorder and schizoaffective disorder is 2-3 fold higher compared with the general population”
Quote in the paperNot a substantial claim - Findingcitation
In severe mental illness patients, cardiovascular disease is the commonest cause of death.
“in SMI patients, CVD is the commonest cause of death”
Quote in the paperNot a substantial claim - Findingcitation
There is evidence that diabetes patients with mental health conditions are less likely to receive standard levels of diabetes care.
“There is evidence that diabetes patients with mental health conditions are less likely to receive standard levels of diabetes care”
Quote in the paperSubstantial claim - Findingcitation
Lack of seeking medical care by severe mental illness patients themselves is an important barrier, even during acute cardiovascular syndromes.
“Another important barrier is the lack of seeking medical care by SMI patients themselves, even during acute cardiovascular syndromes”
Quote in the paperNot a substantial claim - Findingcitation
The preponderance of evidence suggests that patients with major depression, bipolar disorder and schizophrenia are at significantly higher risk for cardiovascular morbidity and mortality than their counterparts in the general population.
“The preponderance of evidence suggests that patients with major depression, bipolar disorder and schizophrenia are at significantly higher risk for cardiovascular morbidity and mortality than are their counterparts in the general population”
Quote in the paperSubstantial claim - Findingcitation
The care of severe mental illness patients shows a significant deficit in the monitoring of cholesterol values and the prescription of statins.
“The care of these patients shows a significant deficit in the monitoring of cholesterol values and the prescription of statins”
Quote in the paperSubstantial claim - Findingcitation
Severe mental illness patients have low rates of surgical interventions, such as stenting and coronary artery bypass grafting.
“They also have low rates of surgical interventions, such as stenting and coronary artery bypass grafting”
Quote in the paperNot a substantial claim - Premisecitation
People with schizophrenia have a 2.8 to 3.5 increased likelihood of being obese.
“People with schizophrenia have a 2.8 to 3.5 increased likelihood of being obese”
Quote in the paperNot a substantial claim - Premisecitation
Severe mental illness and obesity overlap to a clinically significant extent.
“SMI and obesity overlap to a clinically significant extent”
Quote in the paperNot a substantial claim - Premisecitation
The risk of diabetes mellitus in people with depression or depressive symptoms is 1.2-2.6 times higher compared to people without depression.
“The risk of DM in people with depression or depressive symptoms is 1.2-2.6 times higher compared to people without depression”
Quote in the paperNot a substantial claim - Premisecitation
People with major depression or bipolar disorder have a 1.2 to 1.5 increased likelihood of being obese (BMI ≥30).
“those with major depres-sion or bipolar disorder have a 1.2 to 1.5 increased likelihood of being obese (BMI ≥30)”
Quote in the paperNot a substantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
People with severe mental illness have an excess mortality that is two or three times as high as in the general population.
“people with severe mental illness (SMI), including schizophrenia, bipolar disorder, schizoaffective disorder and major depressive disorder, have an excess mortality, being two or three times as high as that in the general population”
Quote in the paperNot a substantial claim - Premisenone given§ WPA EDUCATIONAL MODULE
Individuals with severe mental illness are prone to many different physical health problems.
“Individuals with SMI are prone to many different physical health problems”
Quote in the paperSubstantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
About 60% of the excess mortality in severe mental illness is due to physical illness.
“About 60% of this excess mortality is due to physical illness”
Quote in the paperNot a substantial claim - Premisecitation
Countries in North and South America reported a relatively higher prevalence of the metabolic syndrome than other countries or regions in the world.
“Countries in North and South America (151-154) reported a relatively higher prevalence than other countries or regions in the world”
Quote in the paperNot a substantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
The increased morbidity and mortality in severe mental illness are largely due to a higher prevalence of modifiable risk factors, many related to individual lifestyle choices.
“the increased morbidity and mortality seen in this population are largely due to a higher prevalence of modifiable risk factors, many of which are related to individual lifestyle choices”
Quote in the paperNot a substantial claim - Premisecitation
Lifestyle and behavioral patterns such as smoking, physical inactivity, and dietary habits play important roles in the prevalence of the metabolic syndrome in severe mental illness populations.
“lifestyle and behavioral patterns (smoking, physical inactivity, dietary habits) also play important roles in the prevalence of the MetS in SMI populations”
Quote in the paperNot a substantial claim - Premisecitation
Canadian and US studies reported rates of obesity (BMI ≥30) in patients with schizophrenia of 42-60%.
“Several Canadian and US studies reported rates of obesity (BMI ≥30) in patients with schizophrenia of 42-60%”
Quote in the paperNot a substantial claim - Premisecitation
Metabolic syndrome rates in patients with schizoaffective disorder have been reported to be 42%.
“MetS rates in patients with bipolar disorder and schizoaffective disorder have been reported to be 22-30% (143,169,170) and 42% (171), respectively”
Quote in the paperNot a substantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
The impact of physical diseases on individuals with severe mental illness is significantly greater than in the general population.
“While these diseases are also prevalent in the general population, their impact on individuals with SMI is significantly greater”
Quote in the paperSubstantial claim - Premisecitation
All antipsychotics have been found to cause significant weight gain in antipsychotic-naïve or first-episode patients.
“all AP have been found to cause significant weight gain in APnaïve or first-episode patients”
Quote in the paperNot a substantial claim - Premisecitation
The proportion of individuals experiencing ≥7% weight gain is greater with any atypical antipsychotic than with placebo.
“the proportion of individuals experiencing ≥7% weight gain is greater with any atypical AP than with placebo”
Quote in the paperNot a substantial claim - Premisecitation
Follow-up metabolic assessments were done in only 8.8% of patients initiating a novel antipsychotic.
“follow-up assessments done in only 8.8% of patients”
Quote in the paperNot a substantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
A confluence of patient, provider, and system factors has created problematic access to and quality of health care for individuals with severe mental illness.
“A confluence of patient, provider, and system factors has created a situation in which access to and quality of health care is problematic for individuals with SMI”
Quote in the paperSubstantial claim - Premisecitation§ WPA EDUCATIONAL MODULE
The mortality gap in severe mental illness translates to a 13-30 year shortened life expectancy.
“This mortality gap, which translates to a 13-30 year shortened life expectancy in SMI patients”
Quote in the paperNot a substantial claim - Premisecitation
Depending on used metabolic syndrome criteria, gender, ethnicity, country, age groups and antipsychotic treatment, percentages of metabolic syndrome in schizophrenia vary between 19.4% and 68%.
“Depending on used MetS criteria, gender, ethnicity, country, age groups and AP treatment, percentages vary considerably (between 19.4% and 68%)”
Quote in the paperNot a substantial claim - Interpretationreasoning
No antipsychotic should be considered truly weight-neutral.
“No agent, however, should be considered as truly weight-neutral”
Quote in the paperNot a substantial claim - Premisecitation
Large-scale pharmacoepidemiologic studies of individuals initiating a novel antipsychotic reported low mean baseline metabolic testing rates varying between 8% and less than 30%.
“Several large-scale pharmacoepidemiologic studies of individuals initiating a novel AP (with non-psychiatric large control groups) reported low mean baseline metabolic testing rates, varying between 8% and less than 30%”
Quote in the paperNot a substantial claim - Interpretationcitation
An increase in well-established diabetes mellitus risk factors in severe mental illness patients partially accounts for much of the increased risk.
“An increase in well-established DM risk factors in these patients partially accounts for much of the increased risk”
Quote in the paperNot a substantial claim - Premisecitation
Compared to the general population, the prevalence of diabetes mellitus in schizophrenia patients is 4 to 5 times higher in different age groups.
“compared to the general population, the prevalence of DM in schizophrenia patients is 4 to 5 times higher in different age groups”
Quote in the paperNot a substantial claim - Premisecitation
Studies show large variations in prevalence estimates of the metabolic syndrome across definitions, countries or regions, gender, ethnicity, and age groups.
“Studies show large variations in prevalence estimates of the MetS across definitions, countries or regions, gender, ethnicity, and age groups”
Quote in the paperNot a substantial claim - Premisecitation
Metabolic syndrome rates in patients with bipolar disorder have been reported to be 22-30%.
“MetS rates in patients with bipolar disorder and schizoaffective disorder have been reported to be 22-30% (143,169,170) and 42% (171), respectively”
Quote in the paperNot a substantial claim - Premisecitation
Up to 68% of treatment-seeking bipolar disorder patients are overweight or obese.
“up to 68% of treatment-seeking bipolar disorder patients are overweight or obese”
Quote in the paperNot a substantial claim - Premisecitation
One study found an obesity rate (BMI ≥30) of 57.8% among those with severe depression.
“One study found an obesity rate (BMI ≥30) of 57.8% among those with severe depression”
Quote in the paperNot a substantial claim - Premisecitation
Rates of incident diabetes mellitus increased two or more times with ziprasidone and sertindole.
“Rates increased two or more times with ziprasidone and sertindole”
Quote in the paperNot a substantial claim - Premisecitation
A recent review of all published larger studies between 1959 and 2007 found the mortality risk for cardiovascular disease to be 35% to 250% higher among persons with bipolar spectrum disorders compared to the general population.
“A recent review of all published larger (>100 patients) studies between 1959 and 2007 found the mortality risk for CVD to be 35% to 250% higher among persons with bipolar spectrum disorders compared to the general population”
Quote in the paperNot a substantial claim - Interpretationcitation
Not all atypical antipsychotics appear to have the same propensity to cause diabetic ketoacidosis.
“not all atypical AP appear to have the same propensity to cause this complication”
Quote in the paperNot a substantial claim - Premisecitation
Studies have found an increased risk of adverse cardiac events in patients using tricyclic antidepressants.
“studies have found an increased risk of adverse cardiac events in patients using tricyclic AD”
Quote in the paperNot a substantial claim - Premisecitation
The risk of coronary heart disease seems to be 2-3.6-fold higher in patients with schizophrenia.
“The risk of coronary heart disease seems to be 2-3.6-foldhigher in patients with schizophrenia”
Quote in the paperNot a substantial claim - Premisecitation
Cardiac mortality in general was higher with sertindole.
“However, cardiac mortality in general was higher with sertindole”
Quote in the paperNot a substantial claim - Premisecitation
The risk of cerebrovascular accident seems to be 1.5 to 2.9 fold higher in patients with schizophrenia.
“The risk of cerebrovascular accident seems to be 1.5 to 2.9 fold higher in patients with schizophrenia”
Quote in the paperNot a substantial claim - Premisecitation
An increased risk of diabetes mellitus is associated with the long-term use of both tricyclic antidepressants (IRR=1.77) and SSRIs (IRR=2.06) in at least moderate daily doses.
“the long-term use of both tricyclic AD (incidence rate ratio, IRR=1.77) and SSRIs (IRR=2.06) in at least moderate daily doses”
Quote in the paperNot a substantial claim - Premisereasoning
The excess cardiovascular disease mortality associated with schizophrenia and bipolar disorder is widely attributed to the 1-5 fold relative risk of the modifiable cardiovascular disease risk factors in this group of patients compared with the general population.
“The excess CVD mortality associated with schizophrenia and bipolar disorder is widely attributed to the 1-5 fold RR of the modifiable CVD risk factors in this group of patients compared with the general population”
Quote in the paperNot a substantial claim - Premisecitation
Antidepressants may also increase the risk of diabetes mellitus, probably partly due to side effects such as sedation, increased appetite, and weight gain.
“AD may also increase the risk of DM, probably partly due to side effects such as sedation, increased appetite, and weight gain”
Quote in the paperNot a substantial claim - Premisecitation
An increased risk of diabetes mellitus is associated with the concurrent use of tricyclic antidepressants and serotonin reuptake inhibitors (OR=1.89).
“an increased risk of DM is associated with the concurrent use of tricyclic AD and serotonin reuptake inhibitors (SSRIs) (OR=1.89)”
Quote in the paperNot a substantial claim - Premisecitation
The relative risk of myocardial infarction in people with major affective disorder was found to be 1.7 to 4.5.
“The RR of myocardial infarction in people with major affective disorder was found to be 1.7 to 4.5”
Quote in the paperNot a substantial claim - Premisecitation
The incidence of diabetic ketoacidosis for each atypical antipsychotic over a 7-year period was clozapine 2.2%, olanzapine 0.8%, and risperidone 0.2%.
“The incidence of DKA for each atypical AP over a 7-year period was as follows: clozapine, 2.2%; olanzapine, 0.8%; and risperidone, 0.2%”
Quote in the paperNot a substantial claim - Premisecitation
Depression is an independent risk factor for aggravating morbidity and mortality in coronary heart disease.
“depression is an independent risk factor for aggravating morbidity and mortality in coronary heart disease”
Quote in the paperNot a substantial claim - Premisecitation
People with depression have a 50% greater risk of cardiovascular disease.
“People with depression have a 50% greater risk of CVD”
Quote in the paperNot a substantial claim - Premisecitation
Patients using antipsychotics have higher rates of cardiac arrest or ventricular arrhythmias than controls, with ratios ranging from 1.7 to 5.3.
“Patients using AP have higher rates of cardiac arrest or ventricular arrhythmias than controls, with ratios ranging from 1.7 to 5.3”
Quote in the paperNot a substantial claim - Premisecitation
An increased risk of diabetes mellitus is associated with the use of antidepressant medication in high-risk patients.
“as well as the use of AD medication in high-risk patients”
Quote in the paperNot a substantial claim - Premisecitation
People with bipolar disorder have a 2.1 fold higher risk of coronary heart disease.
“People with bipolar disorder have a 2.1 fold higher risk”
Quote in the paperNot a substantial claim - Premisecitation
Higher antipsychotic doses predicted greater risk of mortality from coronary heart disease and cerebrovascular accident.
“Evidence was found that higher AP doses predicted greater risk of mortality from coronary heart disease and cerebrovascular accident”
Quote in the paperNot a substantial claim - Premisecitation
A recent publication demonstrated that atypical antipsychotic D2 antagonism could have a direct effect on the development of insulin resistance.
“A recent publication demonstrated that atypical AP D 2 antagonism could have a direct effect on the development of insulin resistance”
Quote in the paperNot a substantial claim - Interpretationreasoning
The inconsistency of findings on antipsychotic medication and glycaemic abnormalities suggests that medication effects interact with patient, illness, cohort and study-specific factors.
“this inconsistency of findings suggests that medication effects interact with patient, illness, cohort and study-specific factors”
Quote in the paperSubstantial claim - Interpretationcitation
There appears to be a direct effect of antipsychotics that contributes to the worsening of cardiovascular disease risk.
“there appears to be a direct effect of AP that contributes to the worsening of CVD risk”
Quote in the paperNot a substantial claim - Premisenone given
Cases of torsade de pointes have been reported with thioridazine, haloperidol, ziprasidone, olanzapine, and tricyclic antidepressants.
“Cases of torsade de pointes have been reported with thioridazine, haloperidol, ziprasidone, olanzapine, and tricyclic AD”
Quote in the paperNot a substantial claim - Premisecitation
The risk of cerebrovascular accident seems to be 2.1 to 3.3 fold higher in patients with bipolar disorder.
“and 2.1 to 3.3 fold higher in patients with bipolar disorder”
Quote in the paperNot a substantial claim - Premisecitation
In the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study, the non-treatment rate for diabetes mellitus was 45.3%.
“In the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study, non-treatment rate for DM was 45.3%”
Quote in the paperNot a substantial claim - Premisecitation
The relative risk of developing cerebrovascular accident for patients with major affective disorder was found to be 1.22 to 2.6.
“The RR of developing cerebrovascular accident for patients with major affective disorder was found to be 1.22 to 2.6”
Quote in the paperNot a substantial claim - Interpretationcitation
The main factor mediating the link between depression and coronary events seems to be lack of physical activity.
“the main factor mediating the link between depression and coronary events seems to be lack of physical activity”
Quote in the paperNot a substantial claim - Premisecitation
In large epidemiological studies, a dose dependent increased risk of sudden cardiac death has been identified in current users of tricyclic antidepressants.
“In large epidemiological studies, a dose dependent increased risk of sudden cardiac death has been identified in current users of tricyclic AD”
Quote in the paperNot a substantial claim - Premisecitation
A poorer quality of medical care contributes to excess mortality in older people with mental disorders after heart failure.
“A poorer quality of medical care contributes to excess mortality in older people with mental disorders after heart failure”
Quote in the paperNot a substantial claim - Premisecitation
Depression increases the risk of death or nonfatal cardiac events approximately 2.5-fold in patients with established coronary heart disease.
“depression increases the risk of death or nonfatal cardiac events approximately 2.5-fold in patients with coronary heart disease”
Quote in the paperNot a substantial claim - Premisecitation
Across different continents, rates of hepatitis virus infection are markedly elevated in persons with SMI compared to the general population.
“Across different continents, markedly elevated rates of hepatitis virus infection have been reported in persons with SMI compared to the general population (364,396-403).”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [364]
Not checked in the free run.
- cites [396] source
Not checked in the free run.
- cites [397] source
Not checked in the free run.
- cites [398] source
Not checked in the free run.
- cites [399] source
Not checked in the free run.
- cites [400] source
Not checked in the free run.
- cites [401] source
Not checked in the free run.
- cites [402] source
Not checked in the free run.
- cites [403] source
Not checked in the free run.
- Premisecitation
Overall, an estimated 20-25% of persons with SMI are infected with hepatitis C virus.
“Overall, an estimated 20-25% of persons with SMI are infected with hepatitis C virus (360,404-407).”
Quote in the paperNot a substantial claim0 of 5 sources checked - Premisecitation
Today, respiratory diseases are still more prevalent in people with SMI.
“Today, respiratory diseases are still more prevalent in people with SMI (8,(410)(411)(412)(413)(414)(415)(416)(417).”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [8] source
Not checked in the free run.
- cites [410] source
Not checked in the free run.
- cites [411] source
Not checked in the free run.
- cites [412] source
Not checked in the free run.
- cites [413] source
Not checked in the free run.
- cites [414] source
Not checked in the free run.
- cites [415] source
Not checked in the free run.
- cites [416] source
Not checked in the free run.
- cites [417] source
Not checked in the free run.
- Premisecitation
Interventions exist that are specifically designed to facilitate integrated infectious disease programming in mental health settings for people with SMI and to overcome provider- and consumer-level barriers at a modest and specified cost.
“Interventions exist that are specifically designed to facilitate integrated infectious disease programming in mental health settings for people with SMI and to overcome provider-and consumer-level barriers at a modest and specified cost (409).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [409] source
Not checked in the free run.
- Premisecitation
The most common transmission routes for hepatitis in persons with SMI are drug-use behaviors and sexual behaviors related to drug use.
“The most common transmission routes for persons with SMI are drug-use behaviors and sexual behaviors related to drug use (404-406).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
These rates of chronic bronchitis and asthma were significantly higher than those of matched controls from the general population.
“These rates were significantly higher than those of the matched controls from the general population.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [430] source
Not checked in the free run.
- Premisecitation
Schizophrenia is associated with a 1.37 times greater risk of acute respiratory failure.
“A nationwide, population-based study found schizophrenia to be associated with a 1.37 times greater risk of acute respiratory failure and a 1.34-fold greater risk of mechanical ventilation (428).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [428]
Not checked in the free run.
- Premisecitation
Schizophrenia is associated with a 1.34-fold greater risk of mechanical ventilation.
“A nationwide, population-based study found schizophrenia to be associated with a 1.37 times greater risk of acute respiratory failure and a 1.34-fold greater risk of mechanical ventilation (428).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [428]
Not checked in the free run.
- Premisecitation
The prevalence of chronic obstructive pulmonary disease (chronic bronchitis and emphysema) is significantly higher among those with SMI than comparison subjects.
“The prevalence of chronic obstructive pulmonary disease, i.e. chronic bronchitis and emphysema, is significantly higher among those with SMI than comparison subjects (429-433).”
Quote in the paperNot a substantial claim0 of 5 sources checked - Premisecitation
Significant barriers to prompt and appropriate medical care for pneumonia still persist for patients who have schizophrenia.
“Significant barriers to prompt and appropriate medical care for pneumonia still persist for patients who have schizophrenia (428).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [428]
Not checked in the free run.
- Premisecitation
Even when smoking was controlled for as a confounder, both people with schizophrenia and bipolar disorder were more likely to suffer from emphysema.
“The authors also found that, even when smoking was controlled for as a confounder, both people with schizophrenia and bipolar disorder were more likely to suffer from emphysema (430).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [430] source
Not checked in the free run.
- Premisecitation
Studies exploring the relationship between SMI and all cancer types together have shown conflicting results.
“However, studies exploring the relationship between SMI and all cancer types together have shown conflicting results (30,439).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Some studies have demonstrated a decreased cancer risk in schizophrenia.
“Some studies have demonstrated a decreased cancer risk in schizophrenia (440-448).”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [440] source
Not checked in the free run.
- cites [441] source
Not checked in the free run.
- cites [442]
Not checked in the free run.
- cites [443] source
Not checked in the free run.
- cites [444] source
Not checked in the free run.
- cites [445] source
Not checked in the free run.
- cites [446] source
Not checked in the free run.
- cites [447] source
Not checked in the free run.
- cites [448] source
Not checked in the free run.
- Premisecitation
People with SMI are less likely to receive routine cancer screening.
“For example, people with SMI are less likely to receive routine cancer screening (457-460).”
Quote in the paperSubstantial claim0 of 4 sources checked - Premisecitation
Schizophrenia, schizoaffective states, major depression and bipolar disorder are known to be associated with low bone mineral density.
“Schizophrenia, schizoaffective states, major depression and bipolar disorder are known to be associated with low bone mineral density (BMD) (470).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [470] source
Not checked in the free run.
- Premisecitation
In comparison with the general population, untreated patients with schizophrenia appear to have an increased risk of developing osteoporosis.
“In comparison with the general population, untreated patients with schizophrenia appear to have an increased risk of developing osteoporosis.”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [470] source
Not checked in the free run.
- cites [471] source
Not checked in the free run.
- cites [472] source
Not checked in the free run.
- cites [473] source
Not checked in the free run.
- cites [474]
Not checked in the free run.
- cites [475] source
Not checked in the free run.
- cites [476] source
Not checked in the free run.
- Premisecitation
Clinical data implicating antipsychotic-induced hyperprolactinemia as a possible major risk factor for bone loss are limited and contradictory.
“Although it has been suggested that raised prolactin levels provoked by AP medication can lead to an increased risk of osteoporosis in patients with schizophrenia (471, 487), clinical data implicating AP-induced hyperprolactinemia as a possible major risk factor for bone loss are limited and contradictory (488,489).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The majority of studies directly examining the relationship between antidepressants and bone mineral density in humans report that the use of these medications is associated with low bone mineral density.
“The majority of studies directly examining the relationship between AD and BMD in humans report that the use of these medications is associated with low BMD (486).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [486] source
Not checked in the free run.
- Premisecitation
Other studies have found significant increases (OR=1.2-2.6) in the risk of fractures associated with antipsychotics.
“Other studies (506-510) have found significant increases (OR=1.2-2.6) in the risk of fractures associated with AP.”
Quote in the paperNot a substantial claim0 of 5 sources checked - Premisecitation
Some studies have reported higher prevalence rates of osteoporotic fractures in patients with chronic schizophrenia, entirely or partly independent of the use of antipsychotics.
“Some of these studies have reported higher prevalence rates of osteoporotic fractures in patients with chronic schizophrenia, entirely or partly independent of the use of AP (504,505).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
For antidepressants, a dose-response relationship was observed for fracture risk.
“For AD, a dose-response relationship was observed for fracture risk (504,508).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
This finding seems to be restricted to the SSRI class of antidepressants.
“However, this finding seems to be restricted to the SSRI class of AD (500-502).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Regarding antipsychotics, conflicting results exist on osteoporotic fracture risk.
“Regarding AP, conflicting results exist (503).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [503]
Not checked in the free run.
- Interpretationcitation
The available data seem to indicate that hyperprolactinemia with associated hypogonadism may be a risk factor, leading to bone mineral loss in women as well as men.
“Nevertheless, the available data seem to indicate that hyperprolactinemia with associated hypogonadism may be a risk factor (488), leading to bone mineral loss in women as well as men (499).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
SSRIs seem to be associated with the highest adjusted odds of osteoporotic fractures (OR=1.5).
“SSRIs seem to be associated with the highest adjusted odds of osteoporotic fractures (OR=1.5)(504,505, 508).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
A number of mood stabilizers have been associated with fetal malformations, including carbamazepine and valproate.
“Furthermore, a number of mood stabilizers have been associated with fetal malformations, including carbamazepine and valproate (560,561).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
No definitive association has been found up to now between the use of antipsychotics during pregnancy and an increased risk of birth defects or other adverse outcomes.
“However, no definitive association has been found up to now between the use of AP during pregnancy and an increased risk of birth defects or other adverse outcomes (555,556).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationnone given
In summary, many physical disorders have been identified that are more prevalent in individuals with SMI.
“In summary, many physical disorders have been identified that are more prevalent in individuals with SMI.”
Quote in the paperSubstantial claim - Premisecitation
Next to medication effects, lifestyle and diet factors can contribute to the occurrence of constipation in people with SMI (sedentary life, low physical activity, diet low in fibre, limited fluid intake).
“Next to medication effects, lifestyle and diet factors can contribute to the occurrence of constipation in people with SMI (sedentary life, low physical activity, diet low in fibre, limited fluid intake) (584).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [584]
Not checked in the free run.
- The quote only partly states this claim. 2
- May combine two claims. 75
- Classified as probably not a substantial claim. 79
The quote only partly states this claim.
FindingcitationPersons with severe mental illness are at increased risk for overweight, obesity, and abdominal obesity compared to the general population, even in early illness phase and/or without medication.
“persons with SMI are, compared to the general population, at increased risk for overweight (i.e., BMI =25-29.9,unless Asian: BMI =23-24.9),obesity (i.e., BMI ≥30, unless Asian: BMI ≥25) and abdominal obesity”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ WPA EDUCATIONAL MODULENutritional and metabolic diseases, cardiovascular diseases, viral diseases, respiratory tract diseases, musculoskeletal diseases, sexual dysfunction, pregnancy complications, stomatognathic diseases, and possibly obesity-related cancers are more prevalent among people with severe mental illness compared to the general population.
“Nutritional and metabolic diseases, cardiovascular diseases, viral diseases, respiratory tract diseases, musculoskeletal diseases, sexual dysfunction, pregnancy complications, stomatognathic diseases, and possibly obesity-related cancers are, compared to the general population, more prevalent among people with SMI”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationNeither psychiatrists nor primary care physicians carefully screen or monitor patients receiving antipsychotic medication for metabolic risk factors.
“At present, neither psychiatrists nor primary care physicians carefully screen or monitor patients receiving AP medication for metabolic risk factors”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ WPA EDUCATIONAL MODULEBaseline testing of numerous important physical parameters is insufficiently performed in severe mental illness.
“baseline testing of numerous important physical parameters is insufficiently performed”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe metabolic syndrome remains widely underdiagnosed and undertreated among patients with severe mental illness.
“The MetS remains, thus, widely underdiagnosed and undertreated among patients with SMI”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationPeople with schizophrenia are not being adequately screened and treated for dyslipidemia (up to 88% untreated) and hypertension (up to 62% untreated).
“people with schizophrenia are not being adequately screened and treated for dyslipidemia (up to 88% untreated) and hypertension (up to 62% untreated)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningIt is unclear whether or not specific antidepressants themselves may increase the risk of diabetes mellitus.
“it is unclear whether or not specific AD themselves may increase the risk of DM”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationPeople with severe mental illness have significantly higher rates of several modifiable risk factors compared with controls; they are more likely to be overweight or obese, to have diabetes mellitus, hypertension, or dyslipidemia and to smoke.
“People with SMI have significantly higher rates of several of the modifiable risk factors compared with controls.They are more likely to be overweight or obese, to have DM, hypertension, or dyslipidemia and to smoke”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationSevere mental illness patients have the highest cardiovascular disease mortality but the least chance of receiving many specialized interventions or circulatory medications.
“SMI patients have the highest CVD mortality but the least chance of receiving many specialized interventions or circulatory medications”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenPatients with severe mental illness are at increased risk for a variety of chronic viral infections, of which the most serious are the diseases associated with human immunodeficiency virus and hepatitis C virus.
“Patients with SMI are at increased risk for a variety of chronic viral infections, of which the most serious are the diseases associated with human immunodeficiency virus (HIV) and hepatitis C virus”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationScreening rates for metabolic abnormalities in people with severe mental illness remain low despite clear guidance and a high prevalence of undiagnosed diabetes mellitus, which may lead to prolonged periods of poor glycaemic control.
“Despite clear guidance and a high prevalence of undiagnosed DM, screening rates for metabolic abnormalities in people with SMI remain low, which may lead to prolonged periods of poor glycaemic control”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
PremisecitationIn the only study to date in first-episode patients, diabetes mellitus development was promoted by initial treatment with olanzapine (HR=1.41) and mid-potency conventional antipsychotics (HR=1.60), as well as by current treatment with low-potency conventional antipsychotics (OR=1.52), olanzapine (OR=1.44) and clozapine (OR=1.67).
“In the only study to date in first-episode patients, DM development was promoted in patients with schizophrenia by initial treatment with olanzapine (hazard ratio, HR=1.41) and mid-potency conventional AP (HR=1.60),as well as by current treatment with low-potency conventional AP (odds ratio, OR=1.52), olanzapine (OR= 1.44) and clozapine (OR=1.67)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWeight gain is greatest with clozapine and olanzapine, intermediate with quetiapine and risperidone, and little with aripiprazole, asenapine, amisulpride and ziprasidone.
“Weight gain is greatest with clozapine and olanzapine (107,108), while quetiapine and risperidone have an intermediate risk.Aripiprazole, asenapine, amisulpride and ziprasidone have little effect on weight”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA large-scale pharmacoepidemiologic study found low to moderate but significantly increased rates of incident diabetes mellitus compared with the general population for clozapine (RR=1.45), olanzapine (RR=1.29) and risperidone (RR=1.23).
“A recent large-scale pharmacoepidemiologic study (including 345,937 patients who purchased antipsychotics and 1,426,488 unexposed individuals) found low to moderate, but significantly increased rates of incident DM compared with the general population for clozapine (RR=1.45),olanzapine (RR=1.29)and risperidone (RR=1.23)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStudies of genetic predictors of weight gain under antipsychotic therapy have mainly focused on HTR2C and LEPR gene polymorphisms.
“Studies of genetic predictors of weight gain under AP therapy have mainly but not exclusively (131) focused on HTR2C (132-135) and LEPR (135,136) gene polymorphisms”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is growing evidence for weight gain effects similar to those in schizophrenia in patients with bipolar disorder.
“There is growing evidence for similar effects in patients with bipolar disorder”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOf the atypical antipsychotics, olanzapine and clozapine and, to a lesser extent, quetiapine and risperidone are associated with an increased risk of diabetes mellitus in people who have schizophrenia or bipolar disorder.
“Of the atypical AP, specifically olanzapine (231-234) and clozapine (232,234,235) and, to a lesser extent, quetiapine (236) and risperidone (237), are associated with an increased risk of DM (80) in people who have schizophrenia or bipolar disorder”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationHigh interindividual variability in medication-induced weight gain suggests that genetic factors influence the risk to gain weight.
“The high interindividual variability in medication-induced weight gain suggests that genetic factors influence the risk to gain weight”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWeight gain during acute and maintenance treatment of patients with schizophrenia is a well established side effect of antipsychotics, affecting between 15 and 72% of patients.
“Weight gain during acute and maintenance treatment of patients with schizophrenia is a well established side effect of antipsychotics (AP), affecting between 15 and 72% of patients”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe reason for the increased risk of diabetes mellitus in severe mental illness patients is multifactorial and includes genetic and lifestyle factors as well as disease and treatment specific effects.
“The reason for the increased risk of DM in SMI patients is multifactorial and includes genetic and lifestyle factors as well as disease and treatment specific effects”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAripiprazole, amisulpride and quetiapine did not have a significantly increased rate of incident diabetes mellitus.
“Aripiprazole, amisulpride and quetiapine did not have a significantly increased rate”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAntidepressants such as paroxetine and mood stabilizers such as lithium and valproate have been associated with weight gain.
“Equally, antidepressants (AD) such as paroxetine (116), and mood stabilizers, such as lithium and valproate (117-119), have been associated with weight gain”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAtypical antipsychotics seem to have a stronger diabetogenic risk than conventional antipsychotics, with the risk being 1.3 fold higher in people with schizophrenia taking atypical antipsychotics compared with those receiving conventional antipsychotics.
“Atypical AP seem to have a stronger diabetogenic risk than conventional AP (96,228,229), the risk being 1.3 fold higher in people with schizophrenia taking atypical AP compared with those receiving conventional AP”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ WPA EDUCATIONAL MODULEThe somatic well-being of people with severe mental illness has been neglected for decades and still is today.
“It seems that the somatic well being of people with a (severe) mental illness has been neglected for decades (15), and still is today”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is agreement that the major characteristics of the metabolic syndrome include central obesity, hypertension, dyslipidemia, glucose intolerance or insulin resistance.
“there is agreement that the major characteristics of the syndrome include central obesity, hypertension, dyslipidemia, glucose intolerance or insulin resistance”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is evidence supporting the hypothesis that the metabolic syndrome or its components may be important etiologic factors for certain cancers, such as colon cancer.
“There is also evidence supporting the hypothesis that the MetS or components of the MetS may be important etiologic factors for certain cancers (e.g., colon cancer)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is a hierarchy for risk of weight gain with antipsychotics that has been confirmed in different studies and meta-analyses.
“There is a hierarchy for risk of weight gain with AP that has been confirmed in different studies and meta-analyses”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisecitationOne large study found that the ten-year coronary heart disease risk was significantly elevated in male (9.4% vs. 7.0%) and female (6.3% vs. 4.2%) patients who have schizophrenia compared to controls (p=0.0001).
“One large study found that the tenyear coronary heart disease risk was significantly elevated in male (9.4% vs. 7.0%) and female (6.3% vs. 4.2%) patients who have schizophrenia compared to controls (p=0.0001)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of diabetic ketoacidosis is nearly or more than 10-fold greater in those with schizophrenia compared to the general population.
“The incidence of DKA is nearly (266) or more (267) than 10-fold greater in those with schizophrenia compared to the general population”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe high frequency of substance abuse, sexual risk behaviors, and reduced knowledge about HIV-related issues contribute to the high HIV prevalence in people with SMI.
“The high frequency of substance abuse, sexual risk behaviors (e.g., sex without a condom, trading sex for money and drugs), and a reduced knowledge about HIV-related issues contribute to this high HIV prevalence (364,371-376).”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [364]
Not checked in the free run.
- cites [371] source
Not checked in the free run.
- cites [372]
Not checked in the free run.
- cites [373] source
Not checked in the free run.
- cites [374] source
Not checked in the free run.
- cites [375]
Not checked in the free run.
- cites [376] source
Not checked in the free run.
May combine two claims.
PremisecitationThe mortality of reported cases of diabetic ketoacidosis varies between 15.4% and 48%, which is up to ten times higher than the 4% rate in the general population.
“The mortality of reported cases of DKA varies between 15.4% and 48% (233,235-237), which is up to ten times higher than the 4% rate in the general population”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn patients with antipsychotic monotherapy, a dose-related increased risk of sudden cardiac death was found for both conventional and atypical antipsychotics, with adjusted RRs of 1.31 vs. 1.59 for low dose, 2.01 vs. 2.13 for moderate dose, and 2.42 vs. 2.86 for high dose.
“In patients with AP monotherapy, a similar dose-related increased risk of sudden cardiac death was found for both conventional and atypical AP, with adjusted RRs of 1.31 vs. 1.59 (low dose, chlorpromazine equivalents <100mg), 2.01 vs. 2.13 (moderate dose, chlorpromazine equivalents 100-299mg) and 2.42 vs. 2.86 (high dose, chlorpromazine equivalents ≥300mg), respectively”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe prevalence of cardiovascular disease in people with schizophrenia and bipolar disorder is approximately 2- to 3-fold increased, particularly in younger individuals.
“The prevalence of CVD in people with schizophrenia and bipolar disorder is approximately 2-to 3-fold increased, particularly in younger individuals”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe largest randomized study to date (n=18,154) did not find a statistically significant difference in the risk of sudden cardiac death between ziprasidone and olanzapine treated patients with schizophrenia.
“the largest randomized study to date (n=18,154) did not find a statistically significant difference in the risk of sudden cardiac death between ziprasidone and olanzapine treated patients with schizophrenia”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCases of diabetic ketoacidosis have been reported with the atypical antipsychotics clozapine, olanzapine, quetiapine, risperidone, aripiprazole and ziprasidone.
“Cases of DKA have been reported with the atypical AP clozapine (235,268), olanzapine (233,269), quetiapine (236), risperidone (237), aripiprazole (270-272) and ziprasidone (242)”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe prevalence of HIV positivity in people with severe mental illness (SMI) is generally higher than in the general population, but varies substantially (1.3-23.9%).
“The prevalence of HIV positivity in people with SMI is generally higher than in the general population, but varies substantially (1.3-23.9%)(347-370).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 347-370
Not checked in the free run.
The quote only partly states this claim.
PremisecitationCurrent aripiprazole treatment reduced diabetes mellitus risk (OR=0.51) in first-episode patients.
“Current aripiprazole treatment reduced DM risk (OR= 0.51)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMost antipsychotics and some antidepressants may be associated with QTc prolongation.
“Most AP and some AD may be associated with QTc prolongation”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWithin the class of conventional antipsychotics, cases of diabetic ketoacidosis have been reported with chlorpromazine, but no such cases have been reported for other conventional antipsychotics.
“Within the class of conventional AP, cases of DKA have been reported with chlorpromazine (274,275), but no such cases have been reported for other conventional AP”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationValproate has been associated with an elevated risk for the development of insulin resistance, conferring a risk for diabetes mellitus, possibly related to weight gain, fatty liver infiltration, but also to valproate itself.
“certain mood stabilizers, especially valproate, have been associated with an elevated risk for the development of insulin resistance (252,253), conferring a risk for DM, which is possibly related to weight gain (254), and/or fatty liver infiltration (255), but also to valproate itself (256)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoning§ WPA EDUCATIONAL MODULEThis is a selective, rather than a systematic review of clinical data on physical health problems in people with severe mental illness, as not all physical diseases were included.
“This is a selective, rather than a systematic review of clinical data on physical health problems in people with SMI, as we did not include all physical diseases”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisecitationThere are no reported cases of lithium-induced torsade de pointes.
“There are no reported cases of lithium-induced torsade de pointes”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOverall, SSRIs appear safe in cardiac populations, with few cardiac side effects.
“Overall, SSRIs appear safe in cardiac populations, with few cardiac side effects”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFewer than half of individuals with SMI have been tested for HIV in the past year, with percentages ranging from 17% to 47%.
“However, studies investigating HIV testing rates among individuals with a SMI indicate that fewer than half of these patients (percentages ranging from 17% to 47%) have been tested in the past year (378-394).”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [378] source
Not checked in the free run.
- cites [379] source
Not checked in the free run.
- cites [380] source
Not checked in the free run.
- cites [381] source
Not checked in the free run.
- cites [382] source
Not checked in the free run.
- cites [383] source
Not checked in the free run.
- cites [384] source
Not checked in the free run.
- cites [385] source
Not checked in the free run.
- cites [386] source
Not checked in the free run.
- cites [387] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is a consensus that QTc values >500 msec, or an absolute increase of 60 msec compared with drug-free baseline, puts a patient at significant risk of torsade de pointes, ventricular fibrillation and sudden cardiac death.
“There is a consensus that QTc values >500 msec, or an absolute increase of 60 msec compared with drug-free baseline, puts a patient at significant risk of torsade de pointes, ventricular fibrillation and sudden cardiac death”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationObesity, diabetes mellitus, cardiovascular disease as well as depressive symptoms are recognized as risk factors for cerebrovascular accident.
“Obesity, DM, CVD as well as depressive symptoms are recognized as risk factors for cerebrovascular accident”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAntipsychotics associated with a greater risk of QTc prolongation include pimozide, thioridazine and mesoridazine among the conventional antipsychotics and sertindole and ziprasidone among the atypical antipsychotics.
“AP associated with a greater risk of QTc prolongation include pimozide, thioridazine and mesoridazine among the conventional AP (94,335,336) and sertindole and ziprasidone among the atypical AP”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOne study (n=76,799) found unadjusted ORs of 1.24 for no hemoglobin A1c testing, 1.25 for no low-density lipoprotein cholesterol testing, 1.05 for no eye examination, 1.32 for poor glycemic control, and 1.17 for poor lipaemic control.
“One study (n=76,799), examining the impact of mental illness on DM management, found the unadjusted OR to be 1.24 (1.22-1.27)for no hemoglobin A(1c) testing, 1.25 (1.23-1.28)for no low-density lipoprotein cholesterol testing, 1.05 (1.03-1.07)for no eye examination, 1.32 (1.30-1.35)for poor glycemic control, and 1.17 (1.15-1.20)for poor lipaemic control”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningLarge randomized studies focused on a low incidence serious side effect lack power and, possibly, generalizability.
“These large randomized studies, which focused on a low incidence serious side effect, suffer from the problem that they did not enrich samples for cardiac risk, so that they lack power and, possibly, generalizability”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPatients with schizophrenia have been reported to be three times as likely to experience sudden cardiac death as individuals from the general population.
“Patients with schizophrenia have been reported to be three times as likely to experience sudden cardiac death as individuals from the general population”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenTricyclic antidepressants commonly increase heart rate by over 10%, induce orthostatic hypotension, slow cardiac conduction, and increase the risk of arrhythmias.
“Tricyclic AD commonly increase heart rate by over 10%, induce orthostatic hypotension, slow cardiac conduction, and increase the risk of arrhythmias”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenAlthough SSRIs have been associated with QTc prolongation, no cases of torsade de pointes have been reported with the use of these agents.
“Although SSRIs have been associated with QTc prolongation, no cases of torsade de pointes have been reported with the use of these agents”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnother large randomized study (n=9,858) observed no significant differences between sertindole and risperidone recipients in cardiac events, including arrhythmias, requiring hospitalization.
“another large randomized study (n=9,858) observed no significant differences between sertindole and risperidone recipients in cardiac events, including arrhythmias, requiring hospitalization”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAn analysis of the FDA's diabetes mellitus-related adverse events database found adjusted reporting ratios for diabetes mellitus relative to all drugs and events of olanzapine 9.6, risperidone 3.8, quetiapine 3.5, clozapine 3.1, ziprasidone 2.4, aripiprazole 2.4, and haloperidol 2.0.
“An analysis of the FDA's DM-related adverse events database (ranging from new-onset hyperglycemia to life-threatening ketoacidosis), found the following adjusted reporting ratios for DM relative to all drugs and events: olanzapine 9.6 (9.2-10.0);risperidone 3.8 (3.5-4.1);quetiapine 3.5 (3.2-3.9);clozapine 3.1 (2.9-3.3);ziprasidone 2.4 (2.0-2.9);aripiprazole 2.4 (1.9-2.9);haloperidol 2.0 (1.7-2.3)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn general, lithium can be safely used in cardiac patients.
“in general, lithium can be safely used in cardiac patients”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningHigher incidence rates of diabetic ketoacidosis for clozapine and olanzapine can be due to reporting and detection biases.
“higher incidence rates for clozapine and olanzapine can be due to reporting and detection biases”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe aetiology of excess cardiovascular disease in severe mental illness is multifactorial and likely includes genetic and lifestyle factors as well as disease specific and treatment effects.
“The aetiology of this excess CVD is multifactorial and likely includes genetic and lifestyle factors as well as disease specific and treatment effects”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA systematic review of 22 prospective, randomized, controlled trials found no difference in the incidence of glycaemic abnormalities between placebo cohorts and antipsychotic medication cohorts, as well as no significant difference between any of the antipsychotic medications studied in terms of their association with glycaemic abnormalities.
“a systematic review of 22 prospective, randomized, controlled trials found no difference in the incidence of glycaemic abnormalities between placebo cohorts and AP medication cohorts, as well as no significant difference between any of the AP medications studied in terms of their association with glycaemic abnormalities”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the largest study to date, prevalence rates of hepatitis B virus (23.4%) and hepatitis C virus (19.6%) in SMI patients were approximately 5 and 11 times the overall estimated population rates for these infections.
“The largest study to date found prevalence rates of hepatitis B virus (23.4%) and hepatitis C virus (19.6%) in SMI patients to be approximately 5 and 11 times the overall estimated population rates for these infections.”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [364]
Not checked in the free run.
- cites [396] source
Not checked in the free run.
- cites [397] source
Not checked in the free run.
- cites [398] source
Not checked in the free run.
- cites [399] source
Not checked in the free run.
- cites [400] source
Not checked in the free run.
- cites [401] source
Not checked in the free run.
- cites [402] source
Not checked in the free run.
- cites [403] source
Not checked in the free run.
May combine two claims.
InterpretationcitationPatients with SMI exposed to atypical antipsychotics and patients infected with HIV on highly active antiretroviral therapy are at particularly high risk for developing metabolic syndrome and ultimately cardiovascular disease.
“Since many patients with SMI are exposed to atypical AP, which have been associated with metabolic abnormalities, and since patients infected with HIV and on highly active antiretroviral therapy may also develop metabolic abnormalities, this group of patients is at particularly high risk for developing MetS and ultimately CVD (395).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [395] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study showed that assignment of people with SMI to the STIRR intervention had high levels (over 80%) of participation and acceptance of core services (testing for hepatitis C, immunization against hepatitis, knowledge about hepatitis).
“A recent study showed that the assignment of people with SMI to the “STIRR” (Screening, Testing, Immunization, Risk reduction counseling, medical treatment Referral) intervention had high levels (over 80%) of participation and acceptance of core services (testing for hepatitis C, immunization against hepatitis, knowledge about hepatitis) (407).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [407] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStudies consistently show a higher incidence of tuberculosis among patients with schizophrenia compared with the general population.
“Studies consistently show a higher incidence of tuberculosis among patients with schizophrenia compared with the general population (422-426).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [422]
Not checked in the free run.
- cites [423] source
Not checked in the free run.
- cites [424]
Not checked in the free run.
- cites [425]
Not checked in the free run.
- cites [426]
Not checked in the free run.
May combine two claims.
PremisecitationPeople with SMI have a higher prevalence of angina and respiratory symptoms and impaired lung function compared with the general population.
“Filik et al (414) found that people with SMI have a higher prevalence of angina and respiratory symptoms and impaired lung function when compared with the general population.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [414] source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of 200 outpatients in the US, 15% of those with schizophrenia and 25% of those with bipolar disorder had chronic bronchitis, and 16% of people with schizophrenia and 19% of people with bipolar disorder had asthma.
“In a study of 200 outpatients in the US, 15% of those with schizophrenia and 25% of those with bipolar disorder had chronic bronchitis, and 16% of people with schizophrenia and 19% of people with bipolar disorder had asthma.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [430] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA higher incidence of chronic obstructive pulmonary disease in the past two decades has been associated with the side effects of phenothiazine conventional antipsychotics, although the association remains unclear.
“Although the association remains unclear, a higher incidence of chronic obstructive pulmonary disease in the past two decades has been associated with the side effects of phenothiazine conventional AP (434).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [434]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOther studies found an increased or no different overall risk of cancer in patients with schizophrenia compared to the general population.
“On the other hand, other studies found an increased (9,21,28,(449)(450)(451) or no different (292,419,452,453) overall risk of cancer in patients with schizophrenia compared to the general population.”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [9] source
Not checked in the free run.
- cites [21] source
Not checked in the free run.
- cites [28] source
Not checked in the free run.
- cites [449] source
Not checked in the free run.
- cites [450] source
Not checked in the free run.
- cites [451] source
Not checked in the free run.
- cites [292] source
Not checked in the free run.
- cites [419] source
Not checked in the free run.
- cites [452] source
Not checked in the free run.
- cites [453] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe discrepancy of cancer results may be a result of various confounding factors that could artificially lower the rates of diagnosed and reported cancer in SMI populations.
“This discrep-ancy of results may be a result of various confounding factors that could artificially lower the rates of diagnosed and reported cancer in SMI populations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenA problem with most existing data base analyses is that etiologically disparate cancer types were lumped together.
“Nevertheless, a problem with most of the existing data base analyses is that etiologically disparate cancer types were lumped together.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationPatients with SMI have a shorter life expectancy, so they may die from cardiovascular reasons before reaching the expected age of death from cancer.
“Furthermore, patients with SMI have a shorter life expectancy, so they may die from cardiovascular reasons before reaching the expected age of death from cancer (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAn important analysis of cause-specific excess deaths associated with underweight, overweight, and obesity in the general population found that obesity was associated with an increased mortality from cancers considered obesity-related but not with mortality from other cancers.
“An important analysis of cause-specific excess deaths associated with underweight, overweight, and obesity in the general population found that obesity was associated with an increased mortality from cancers considered obesity-related but not with mortality from other cancers (463).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [463] source
Not checked in the free run.
May combine two claims.
PremisecitationIn the population of bipolar spectrum disorders, deaths from cancer are not higher or only slightly elevated compared with the general population, despite the higher number of risk factors for cancer in this population.
“In the population of bipolar spectrum disorders, deaths from cancer are not higher (8,288,416,417,454-456) or only slightly elevated (417,418,456) compared with the general population, despite the higher number of risk factors for cancer (such as obesity) in this population.”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [8] source
Not checked in the free run.
- cites [288] source
Not checked in the free run.
- cites [416] source
Not checked in the free run.
- cites [417] source
Not checked in the free run.
- cites [454] source
Not checked in the free run.
- cites [455] source
Not checked in the free run.
- cites [456] source
Not checked in the free run.
- cites [418] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe increased risk of osteoporosis in untreated schizophrenia is due to the disease itself and to risk factors related to lifestyle (e.g., smoking, reduced physical activity, alcohol abuse, vitamin D and calcium deficiency, polydipsia).
“On the one hand, this is because of the disease itself, on the other hand, because of risk factors related to their lifestyle (e.g., smoking, reduced physical activity, alcohol abuse, vitamin D and calcium deficiency, polydipsia) (470-476).”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [470] source
Not checked in the free run.
- cites [471] source
Not checked in the free run.
- cites [472] source
Not checked in the free run.
- cites [473] source
Not checked in the free run.
- cites [474]
Not checked in the free run.
- cites [475] source
Not checked in the free run.
- cites [476] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe majority of studies investigating the risk of breast cancer in patients treated with conventional antipsychotics did not uncover an increased risk of breast cancer, with an exception being the cohort study by Wang et al.
“The majority of the studies in which the risk of breast cancer has been investigated in patients treated with conventional AP (465-468) did not uncover an increased risk of breast cancer, an exception being the cohort study by Wang et al (469).”
Quote in the paperNot a substantial claim0 of 5 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe current study database on antipsychotics and breast cancer risk is very limited.
“The current study database on AP and breast cancer risk is very limited (464).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [464] source
Not checked in the free run.
May combine two claims.
PremisecitationTwo recent meta-analyses confirmed that depression is associated with low bone mineral density and should be considered as an important risk factor for osteoporosis, although this increased risk may be mediated by antidepressants.
“Two recent meta-analyses confirmed that depression is associated with low BMD and should be considered as an important risk factor for osteoporosis, although this increased risk may be mediated by AD (484,485).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSome studies found a relationship between the use of prolactin-raising medication and low bone mineral density in patients with chronic schizophrenia, while others failed to find a relationship between prolactin, antipsychotics and osteoporosis.
“Some studies (490-493) found a relationship between the use of prolactin-raising medication and low BMD in patients with chronic schizophrenia, while others (474,489,494-498) failed to find a relationship between prolactin, AP and osteoporosis.”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [490] source
Not checked in the free run.
- cites [491] source
Not checked in the free run.
- cites [492] source
Not checked in the free run.
- cites [493] source
Not checked in the free run.
- cites [474]
Not checked in the free run.
- cites [489] source
Not checked in the free run.
- cites [494] source
Not checked in the free run.
- cites [495] source
Not checked in the free run.
- cites [496] source
Not checked in the free run.
- cites [497] source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough the association between depression and loss of bone mineral density has been reported inconsistently, most studies have found low bone mineral density in patients with depressive symptoms or major depressive disorder.
“Although the association between depression and loss of BMD has been reported inconsistently, most studies have found low BMD in patients with depressive symptoms or major depressive disorder (477-483).”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [477] source
Not checked in the free run.
- cites [478] source
Not checked in the free run.
- cites [479] source
Not checked in the free run.
- cites [480] source
Not checked in the free run.
- cites [481] source
Not checked in the free run.
- cites [482] source
Not checked in the free run.
- cites [483] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenData describing the epidemiology of osteoporotic fracture and psychotropics in patients with SMI are limited.
“Data describing the epidemiology of osteoporotic fracture and psychotropics in patients with SMI are limited.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough lithium has a potentially negative impact on bone metabolism, it is associated with lower fracture risk (OR=0.6) and seems to be protective against fractures.
“Although lithium has a potentially negative impact on bone metabolism (470), it is associated with lower fracture risk (OR=0.6)and, thus, seems to be protective against fractures (504,505).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationA meta-analysis showed a 33% increased risk of fractures with SSRIs compared to non-SSRI antidepressants; the RR of fractures was 1.60 for antidepressants and 1.59 for antipsychotics.
“A metaanalysis showed a 33% increased risk of fractures with SSRIs compared to non-SSRI AD.The RR of fractures in this metaanalysis was 1.60 for AD and 1.59 for AP (511).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [511] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSexual dysfunction in schizophrenia is estimated to be more frequent compared to normal controls and to affect 30-80% of women and 45-80% of men.
“Although there are relatively few systematic investigations concerning sexual disorders in schizophrenia (514), sexual dysfunction in schizophrenia is, compared to normal controls, estimated to be more frequent (515-519) and to affect 30-80% of women and 45-80% of men (512,515, 520-523).”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [515] source
Not checked in the free run.
- cites [516] source
Not checked in the free run.
- cites [517]
Not checked in the free run.
- cites [518] source
Not checked in the free run.
- cites [519] source
Not checked in the free run.
- cites [512] source
Not checked in the free run.
- cites [520] source
Not checked in the free run.
- cites [521] source
Not checked in the free run.
- cites [522] source
Not checked in the free run.
- cites [523] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSexual dysfunction in SMI patients has received little attention from clinicians.
“Sexual dysfunction in SMI patients has received little attention from clinicians (512,513).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThis low awareness has a significant negative impact on patients' satisfaction with treatment, adherence, quality of life and partner relationships.
“This low awareness has a significant negative impact on patients' satisfaction with treatment, adherence, quality of life and partner relationships (450).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [450] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSexual dysfunction is also a common symptom of depression.
“Sexual dysfunction is also a common symptom of depression (526-530).”
Quote in the paperNot a substantial claim0 of 5 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApproximately 25% of patients with major depression may experience problems with erection or lubrication.
“Approximately 25% of patients with major depression may experience problems with erection or lubrication (531).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [531] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationConventional antipsychotics cause less sexual dysfunction than risperidone but more than the other novel antipsychotics.
“Conventional AP cause less sexual dysfunction than risperidone but more than the other novel AP (520,522).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationUp to 70% of patients with depression may have sexual dysfunction.
“Up to 70% of patients with depression may have sexual dysfunction (466).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [466]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOnly few studies have directly compared the sexual functioning associated with different atypical antipsychotics.
“To date, only few studies (534-547) have directly compared the sexual functioning associated with different atypical AP.”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [534] source
Not checked in the free run.
- cites [535] source
Not checked in the free run.
- cites [536] source
Not checked in the free run.
- cites [537] source
Not checked in the free run.
- cites [538] source
Not checked in the free run.
- cites [539] source
Not checked in the free run.
- cites [540] source
Not checked in the free run.
- cites [541] source
Not checked in the free run.
- cites [542] source
Not checked in the free run.
- cites [543] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFindings suggest that sexual health education for people with SMI tends to produce a reduction in sexual risk behavior.
“However, findings suggest that sexual health education for these people tends to produce a reduction in sexual risk behavior (532).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [532] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThis dysfunction can be secondary to the disease itself and to comorbid physical disorders, or be an adverse event of antipsychotics.
“This dysfunction can be secondary to the disease itself and to comorbid physical disorders, or be an adverse event of AP (520,524,525).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe relative impact of antipsychotics on sexual dysfunction can be summarized as: paliperidone = risperidone > haloperidol > olanzapine ≥ ziprasidone > clozapine ≥ quetiapine > aripiprazole.
“These studies suggest that the relative impact of AP on sexual dysfunction can be summarized as: paliperidone = risperidone > haloperidol > olanzapine ≥ ziprasidone > clozapine ≥ quetiapine > aripiprazole (503,520,536).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAntidepressant therapy (except for mirtazapine, nefazodone and bupropion) frequently induces or exacerbates sexual dysfunction, which occurs in approximately 50% of patients.
“AD therapy (except for mirtazapine, nefazodone and bupropion) frequently induces or exacerbates sexual dysfunction, which occurs in approximately 50% of patients (548).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [548] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPsychotropic drugs are associated with sexual dysfunction.
“Psychotropic drugs are associated with sexual dysfunction (514).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [514]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAlthough sexual dysfunction has been reported with all classes of antidepressants, SSRIs are associated with higher rates.
“Although sexual dysfunction has been reported with all classes of AD (549), SSRIs are associated with higher rates (550-552).”
Quote in the paperNot a substantial claim0 of 4 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is an extensive literature reporting an increased occurrence of obstetric complications among women who have schizophrenia.
“There is an extensive literature reporting an increased occurrence of obstetric complications among women who have schizophrenia (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCurrent evidence seems to suggest that Fallot's tetralogy is not considerably elevated with lithium compared to the rate in the general population.
“Current evidence seems to suggest that Fallot's tetralogy is not considerably elevated with lithium compared to the rate in the general population (560).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [560] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDental health has been consistently found to be poor in people with SMI.
“Dental health has been consistently found to be poor in people with SMI (562-573).”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [562]
Not checked in the free run.
- cites [563] source
Not checked in the free run.
- cites [564] source
Not checked in the free run.
- cites [565]
Not checked in the free run.
- cites [566] source
Not checked in the free run.
- cites [567]
Not checked in the free run.
- cites [568] source
Not checked in the free run.
- cites [569] source
Not checked in the free run.
- cites [570] source
Not checked in the free run.
- cites [571] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost women with SMI cannot stop taking their medication, as this would interfere with their activities of daily living, especially taking care of an infant.
“Most women with a SMI cannot stop taking their medication, as this would interfere with their activities of daily living, especially taking care of an infant (555).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [555] source
Not checked in the free run.
May combine two claims.
PremisecitationAmong antidepressants, SSRIs and, possibly, serotonin and noradrenaline reuptake inhibitors have been associated with preterm labor, respiratory distress, serotonin rebound syndrome, pulmonary hypertension and feeding problems in the neonate.
“Among AD, SSRIs and, possibly, serotonin and noradrenaline reuptake inhibitors (SNRIs) have been associated with preterm labor, respiratory distress, serotonin rebound syndrome, pulmonary hypertension and feeding problems in the neonate (557-559).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPublished studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction.
“Published studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction (553,554).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [553]
Not checked in the free run.
- cites [554] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn one large study (n=4,769), 34.1% of the patients with SMI reported that oral health problems made it difficult for them to eat.
“In one large study (n=4,769), 34.1% of the patients with SMI reported that oral health problems made it difficult for them to eat (572).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [572] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThis poor dental health leads to functional difficulties.
“This poor dental health leads to functional difficulties.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOral health status is a frequently disregarded health issue among SMI patients, with low rates of dental examination within the past 12 months.
“Oral health status is a frequently disregarded health issue among SMI patients (498), with low rates of dental examination within the past 12 months (569,577-579).”
Quote in the paperNot a substantial claim0 of 5 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAntipsychotics, antidepressants and mood stabilizers all cause xerostomia.
“AP, AD and mood stabilizers all cause xerostomia (575).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [575] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAccording to another study, only 42% of patients with schizophrenia brush their teeth regularly (at least twice a day).
“According to another study, only 42% of patients with schizophrenia brush their teeth regularly (at least twice a day) (573).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [573] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA study using an overall dental status index (DMF-T) in chronically hospitalized patients with mental disorders (mostly schizophrenia) found a mean score of 26.74 (out of a possible 32), one of the highest reported in the literature.
“A study using an overall dental status index (DMF-T) in chronically hospitalized patients with mental disorders (mostly schizophrenia) found a mean score of 26.74 (out of a possible 32), one of the highest reported in the literature (571).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [571] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThis reduction in salivary flow changes the oral environment and leads to caries, gingivitis and periodontal disease.
“This reduction in salivary flow changes the oral environment and leads to caries, gingivitis and periodontal disease (576).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [576] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFactors which influence oral health include: type, severity, and stage of mental illness; mood, motivation and self-esteem; lack of perception of oral health problems; habits, lifestyle (e.g., smoking), and ability to sustain self-care and dental attendance; socio-economic factors; effects of medication (dry mouth, carbohydrate craving); and attitudes and knowledge of dental health teams about
“Factors which influence oral health include: type, severity, and stage of mental illness; mood, motivation and selfesteem; lack of perception of oral health problems; habits, lifestyle (e.g., smoking), and ability to sustain self-care and dental attendance; socio-economic factors; effects of medication (dry mouth, carbohydrate craving); and attitudes and knowledge of dental health teams concerning”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [569] source
Not checked in the free run.
- cites [574]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenSome physical conditions, although important, are rarely studied, underreported and not systematically assessed.
“Some physical conditions, although important, are rarely studied, underreported and not systematically assessed.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenClozapine (approximately 0.8%) and phenothiazines (chlorpromazine approximately 0.13%) are the most common causes of drug-related neutropenia/agranulocytosis.
“Clozapine (approximately 0.8%) and phenothiazines (chlorpromazine approximately 0.13%) are the most common causes of drug-related neutropenia/agranulocytosis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenPoor dental status is associated with endocarditis and reduces social and work opportunities.
“Moreover, improving dental health status and care are relevant, as poor dental status is associated with endocarditis and reduces social and work opportunities.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenIn addition to modifiable lifestyle factors and psychotropic medication side effects, poorer access to and quality of received health care remain addressable problems for patients with SMI.
“In addition to modifiable lifestyle factors and psychotropic medication side effects, poorer access to and quality of received health care remain addressable problems for patients with SMI.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenAlthough a common side effect of antipsychotics that can be severe and lead to serious consequences and even death, constipation has been given relatively little attention.
“Although a common side effect of AP that can be severe and lead to serious consequences and even death, constipation has been given relatively little attention.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenConstipation has most widely been reported for clozapine, although it can be associated with other antipsychotics as well.
“Constipation has most widely been reported for clozapine, although it can be associated with other AP as well.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPrevalence of constipation in randomized controlled trials for different antipsychotics is: zotepine 39.6%, clozapine 21.3%, haloperidol 14.6% and risperidone 12%.
“Prevalence of constipation in randomized controlled trials for different AP is: zotepine 39.6%, clozapine 21.3%, haloperidol 14.6% and risperidone 12% (583).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [583] source
Not checked in the free run.
May combine two claims.
PremisecitationIn the latter study, non-adherence to annual dental visits was predicted by substance abuse diagnosis, involuntary legal status, living in an institution, admission to a psychiatric facility for a minimum of 30 days, and male gender, whereas clozapine treatment, novel antipsychotic treatment, at least monthly outpatient visits, and age > 50 years were associated with a lower risk for inappropriate
“In the latter study, non-adherence to annual dental visits was predicted by substance abuse diagnosis, involuntary legal status, living in an institution, admission to a psychiatric facility for a minimum of 30 days, and male gender, whereas clozapine treatment, novel AP treatment, at least monthly outpatient visits, and age > 50 years were associated with a lower risk for inappropriate dental”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [577]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe most reported complications of constipation are paralytic ileus, faecal impaction, bowel obstruction and intestine/bowel perforations.
“The most reported complications of this physical condition are paralytic ileus, faecal impaction, bowel obstruction and intestine/bowel perforations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenHaematological diseases have frequently been described in the literature as potential serious complications of psychotropic medications.
“Haematological diseases, which may in themselves be primary problems in patients with SMI, have frequently been described in the literature as potential serious complications of psychotropic medications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWith appropriate management, the mortality from drug-induced agranulocytosis in Western countries is 5-10% (before the use of antibiotics this percentage was 80%).
“With appropriate management, the mortality from drug-induced agranulocytosis in Western countries is 5-10% (before the use of antibiotics this percentage was 80%) (582).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [582] source
Not checked in the free run.
May combine two claims.
PremisecitationIn one study of a mixed psychiatric population, 15% had not been to a dentist in the last 2 years, while in another only 31% of schizophrenia patients had visited a dentist during a three year period.
“In one study of a mixed psychiatric population, 15% had not been to a dentist in the last 2 years (579), while in another only 31% of schizophrenia patients had visited a dentist during a three year period (577).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [579] source
Not checked in the free run.
- cites [577]
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningGreater individual and system level attention to these physical disorders that can worsen psychiatric stability, treatment adherence, and life expectancy as well as quality of life will improve outcomes of these generally disadvantaged populations worldwide.
“Greater individual and system level attention to these physical disorders that can worsen psychiatric stability, treatment adherence, and life expectancy as well as quality of life will improve outcomes of these generally disadvantaged populations worldwide.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenAntipsychotics (e.g., clozapine, haloperidol, olanzapine, phenothiazines, quetiapine, risperidone, ziprasidone), antidepressants (e.g., amitriptyline, clomipramine, imipramine) as well as lithium are associated with blood dyscrasias.
“AP (e.g., clozapine, haloperidol, olanzapine, phenothiazines, quetiapine, risperidone, ziprasidone), AD (e.g., amitriptyline, clomipramine, imipramine) as well as lithium are associated with blood dyscrasias.”
Quote in the paperNot a substantial claim
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cardiovascular disease is the leading cause of mortality in people with mental illness.
“This has significant clinical implications considering that cardiovascular disease is the leading cause of mortality in people with mental illness [52, 294, 295].”
From Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disorders (2022) · cites this paper as [295]
The “CVD in SMI patients” section (page not provided) says cardiovascular disease is the commonest cause of death among people with severe mental illness. The citing sentence broadens this to people with mental illness generally, which the passage does not establish. (LLM, conf=0.85)
Experimental — accuracy not yet measuredPeople with severe mental illness have higher levels of somatic comorbidities and premature mortality than the general population.
“People with severe mental illness (schizophrenia, bipolar disorder or major depressive disorder) have higher levels of somatic comorbidities and premature mortality than the general population 1-3 .”
Major risk factors for CVD in SMI include antipsychotic medication use and an unhealthy lifestyle.
“Major risk factors include antipsychotic medication use and an unhealthy lifestyle 7”
From Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) · cites this paper as [7]
Factors predisposing people with severe mental illness to cardiovascular diseases include antipsychotic medication and unhealthy lifestyles as well as their reduced likelihood to receive standard levels of medical care.
“Factors predisposing people with SMI to CVD include antipsychotic medication and unhealthy lifestyles (7) as well as their reduced likelihood to receive standard levels of medical care (8)(9)(10)(11)(12).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Upper diabetic ketoacidosis mortality is twelvefold, not tenfold
MinorThe upper reported mortality of 48% is 12 times the general-population rate of 4%, exceeding the stated maximum of ten times.
Reported 10 · recomputed 12
“The mortality of reported cases of DKA varies between 15.4% and 48% (233,235-237), which is up to ten times higher than the 4% rate in the general population (276).”
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,369 · see citing works
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1× · see citing works
“In individuals at high risk, a combination of moderate weight loss, increased physical activity and dietary advice can lead to a 60% reduction in DM incidence (207,208).”
Background‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R. C., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,526 · see citing works
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,452 · see citing works
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820 · see citing works
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · see citing works
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,051 · see citing works
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757 · see citing works
(1998) · PubMed · Cited by 2,737 · see citing works
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382 · see citing works
Organic Causes of Erectile Dysfunction in Men Under 40
Ludwig, W. W., & Phillips, M. (2013) · Urologia Internationalis · doi:10.1159/000354931 · Cited by 2,156 · see citing works
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065 · see citing works
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930 · see citing works
Self-citationExcess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · see citing works
Annual Deaths Attributable to Obesity in the United States
Allison, D. B. (1999) · JAMA · doi:10.1001/jama.282.16.1530 · Cited by 1,868 · see citing works
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · see citing works
(2002) · PubMed · Cited by 1,755 · see citing works
Global strategy on diet, physical activity and health
Samuelson, G. (2004) · Scandinavian Journal of Nutrition · doi:10.1080/11026480410034349 · Cited by 1,750 · see citing works
New Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650 · see citing works
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618 · see citing works
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554 · see citing works
Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M., Graubard, B. I., Williamson, D. F., & Gail, M. H. (2007) · JAMA · doi:10.1001/jama.298.17.2028 · Cited by 1,542 · see citing works
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488 · see citing works
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,369 · see citing works
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354 · see citing works
Association between obesity and psychiatric disorders in the US adult population
Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.824 · Cited by 1,338 · see citing works
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,334 · see citing works
Self-citationMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · see citing works
Bei‐Fan, Z., & the Cooperative Meta‐analysis Group of Working Group on Obesity in China (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.11.s8.9.x · Cited by 1,304 · see citing works
(2006) · Europe PMC (PubMed Central) · Cited by 1,299 · see citing works
Cardiovascular Diseases (CVDs)
de la Zerda, A., & Wang, S. X. (2022) · doi:10.1002/9781118910573.ch5 · Cited by 1,281 · see citing works
Mcevoy, J., Meyer, J., Goff, D., Nasrallah, H., Davis, S., Sullivan, L., Meltzer, H., Hsiao, J. K., Stroup, T., & Lieberman, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,220 · see citing works
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., LAUGHREN, T. P., & Katz, R. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204 · see citing works
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194 · see citing works
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,191 · see citing works
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · see citing works
Depression as a predictor for coronary heart disease
Rugulies, R. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00439-7 · Cited by 1,110 · see citing works
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088 · see citing works
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · see citing works
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070 · see citing works
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · see citing works
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050 · see citing works
Self-citationZhou, Cooperative, B.-F., & on (2002) · 生物医学与环境科学:英文版 · Cited by 992 · see citing works
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · see citing works
Self-citationLaaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916 · see citing works
Hu, F. B., Sigal, R. J., Rich-Edwards, J. W., Colditz, G. A., Solomon, C. G., Willett, W. C., Speizer, F. E., & Manson, J. E. (1999) · JAMA · doi:10.1001/jama.282.15.1433 · Cited by 914 · see citing works
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908 · see citing works
Whooley, M. A. (2008) · JAMA · doi:10.1001/jama.2008.711 · Cited by 887 · see citing works
Mortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881 · see citing works
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869 · see citing works
Zimmet, P., Alberti, K. G. M. M., & Serrano Ríos, M. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60742-1 · Cited by 864 · see citing works
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864 · see citing works
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
Barefoot, J. C., & Schroll, M. (1996) · Circulation · doi:10.1161/01.cir.93.11.1976 · Cited by 850 · see citing works
Physical Activity and Television Watching in Relation to Risk for Type 2 Diabetes Mellitus in Men
Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.12.1542 · Cited by 828 · see citing works
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 821 · see citing works
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812 · see citing works
New Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783 · see citing works
International Diabetes Federation: a consensus on Type 2 diabetes prevention
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02157.x · Cited by 778 · see citing works
Physical Activity of Moderate Intensity and Risk of Type 2 Diabetes
Jeon, C. Y., Lokken, R. P., Hu, F. B., & van Dam, R. M. (2007) · Diabetes Care · doi:10.2337/dc06-1842 · Cited by 758 · see citing works
Size of burden of schizophrenia and psychotic disorders
Wulf Rössler, A., Salize, H. J., van Os, J., & Riecher‐Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 746 · see citing works
Depressive Symptoms and Health-Related Quality of Life
Ruo, B., Rumsfeld, J. S., Hlatky, M. A., Liu, H., Browner, W. S., & Whooley, M. A. (2003) · JAMA · doi:10.1001/jama.290.2.215 · Cited by 742 · see citing works
Definition of Metabolic Syndrome
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. J. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000111245.75752.c6 · Cited by 718 · see citing works
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 716 · see citing works
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 2× · see citing works
“The preponderance of evidence suggests that patients with major depression, bipolar disorder and schizophrenia are at significantly higher risk for cardiovascular morbidity and mortality than are their counterparts in the general population (2,9,11,23,28,29,287-295).”
BackgroundRummel‐Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 679 · see citing works
Self-citationMetabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679 · see citing works
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678 · see citing works
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 654 · see citing works
Review: Inequalities in healthcare provision for people with severe mental illness
Lawrence, D., & Kisely, S. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382058 · Cited by 649 · see citing works
Pratt, L. A., Ford, D. E., Crum, R. M., Armenian, H. K., Gallo, J. J., & Eaton, W. W. (1996) · Circulation · doi:10.1161/01.cir.94.12.3123 · Cited by 643 · see citing works
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634 · see citing works
Self-citationAntipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634 · see citing works
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633 · see citing works
Self-citationDepression and Risk for Onset of Type II Diabetes: A prospective population-based study
Eaton, W. W., Armenian, H. K., Gallo, J. J., Pratt, L., & Ford, D. E. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1097 · Cited by 611 · see citing works
Osborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608 · see citing works
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601 · see citing works
Components of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes
Hanson, R. L., Imperatore, G., Bennett, P. H., & Knowler, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3120 · Cited by 590 · see citing works
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.31 · Cited by 589 · see citing works
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.
Giovannucci, E. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 562 · see citing works
Nasrallah, H. A., Meyer, J. M., GOFF, D. C., McEvoy, J. P., Thomas, S., Stroup, T. S., & Lieberman, J. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.026 · Cited by 553 · see citing works
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551 · see citing works
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547 · see citing works
Equity, social determinants and public health programmes
Mukhopadhyay, A. (2011) · The Indian Journal of Medical Research · Cited by 545 · see citing works
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · see citing works
Body Fat Distribution and Insulin Resistance in Healthy Asian Indians and Caucasians
Raji, A., Seely, E. W., Arky, R. A., & Simonson, D. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7992 · Cited by 541 · cited 1× · see citing works
“Accumulating evidence argues that lower cutoff points for WC should be used for Asians, as this population is prone to obesity-related morbidity and mortality at shorter WCs (52-56).”
BackgroundMental Disorders and Use of Cardiovascular Procedures After Myocardial Infarction
Druss, B. G. (2000) · JAMA · doi:10.1001/jama.283.4.506 · Cited by 533 · see citing works
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528 · see citing works
Psychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502 · see citing works
Petry, N. M., Barry, D., Pietrzak, R. H., & Wagner, J. A. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181651651 · Cited by 494 · see citing works
Bone Mineral Density in Women with Depression
Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471 · see citing works
Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460 · see citing works
Adverse Effects of Atypical Antipsychotics
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 459 · see citing works
Equity, social determinants and public health programmes
Blas, E., & Kurup, A. S. (2010) · University Libraries (University of Maryland) · doi:10.13016/nvnm-a5xt · Cited by 457 · see citing works
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
Fagiolini, A. M., Frank, E., Scott, J., Turkin, S. R., & Kupfer, D. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00234.x · Cited by 451 · see citing works
Bank, W. (2002) · doi:10.1596/0-1952-1606-7 · Cited by 434 · see citing works
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S. K., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 430 · see citing works
Relationship of Physical Activity vs Body Mass Index With Type 2 Diabetes in Women
Weinstein, A. R. (2004) · JAMA · doi:10.1001/jama.292.10.1188 · Cited by 420 · see citing works
Substance Abuse Among the Chronic Mentally Ill
Drake, R. E., & Wallach, M. A. (1989) · Psychiatric Services · doi:10.1176/ps.40.10.1041 · Cited by 419 · see citing works
Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer, J. W. (2007) · PubMed · Cited by 417 · see citing works
Self-citationObesity among those with mental disorders: a National Institute of Mental Health meeting report.
Allison, D., Newcomer, J., Dunn, A., Blumenthal, J., Fabricatore, A., Daumit, G., Cope, M., Riley, W., Vreeland, B., Hibbeln, J., et al. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.11.020 · Cited by 411 · see citing works
Self-citationSerious mental illness and physical health problems: A discussion paper
Robson, D., & Gray, R. (2007) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2006.07.013 · Cited by 411 · see citing works
Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
Reynolds, G. P., & Kirk, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.010 · Cited by 400 · see citing works
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395 · see citing works
Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394 · see citing works
Obesity and mental disorders in the adult general population
Scott, K. M., McGee, M. A., Wells, J. E., & Oakley Browne, M. A. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.09.006 · Cited by 393 · see citing works
Cohen, H. W., Gibson, G., & Alderman, M. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00301-0 · Cited by 390 · see citing works
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383 · see citing works
Laursen, T. M., Munk-Olsen, T., Nordentoft, M., & Mortensen, P. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0612 · Cited by 380 · cited 2× · see citing works
“deaths from cancer are not higher (8,288,416,417,454-456) or only slightly elevated (417,418,456) compared with the”
BackgroundKo, G., Chan, J., Cockram, C., & Woo, J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801043 · Cited by 374 · see citing works
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 372 · see citing works
World Trade Organization (2003) · World Trade Report · doi:10.30875/2a7c3a9e-en · Cited by 368 · see citing works
Hert, M. A. F. D., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 365 · see citing works
Self-citationMitchell, A. J., Malone, D., & Carney, C. P. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045732 · Cited by 359 · see citing works
Gelenberg, A. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0101 · Cited by 356 · see citing works
Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-Year Period
Everson‐Rose, S. A., ROBERTS, R. E., Goldberg, D. E., & Kaplan, G. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1133 · Cited by 355 · see citing works
The health-related quality of life and economic burden of constipation
Dennison, C., Prasad, M., Lloyd, A., Bhattacharyya, S., Dhawan, R., & Coyne, K. (2012) · PharmacoEconomics (Auckland) · doi:10.2165/00019053-200523050-00006 · Cited by 354 · see citing works
Medical comorbidity in women and men with schizophrenia: A population-based controlled study
Carney, C. P., Jones, L., & Woolson, R. F. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00563.x · Cited by 343 · see citing works
Schizophrenia: A Life-shortening Disease
Allebeck, P. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.81 · Cited by 340 · see citing works
Hu, G., Lindström, J., Valle, T. T., Eriksson, J. G., Jousilahti, P., Silventoinen, K., Qiao, Q., & Tuomilehto, J. O. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.8.892 · Cited by 340 · see citing works
Sexual Dysfunction, Depression, and the Impact of Antidepressants
Kennedy, S. H., & Rizvi, S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819c76e9 · Cited by 338 · see citing works
Conley, R. R., & Mahmoud, R. A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.765 · Cited by 336 · see citing works
Disparities in Diabetes Care: Impact of Mental Illness
Frayne, S. M., Halanych, J. H., Miller, D. R., Wang, F., Lin, H., Pogach, L., Sharkansky, E. J., Keane, T. M., Skinner, K. M., Rosen, C. S., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2631 · Cited by 336 · see citing works
Misra, A., Vikram, N. K., Gupta, R., Pandey, R. M., Wasir, J. S., & Gupta, V. P. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803111 · Cited by 332 · see citing works
Falkai, P., Wobrock, T., Lieberman, J. A., Glenthoj, B. Y., Gattaz, W. F., Möller, H., & WFSBP Task Force on Treatment Guide (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 329 · see citing works
Self-citationDiem, S. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1240 · Cited by 326 · see citing works
Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., & Dixon, L. B. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000130135.78017.96 · Cited by 320 · see citing works
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · see citing works
Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus
Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071065 · Cited by 315 · see citing works
Binder, M. D., van Winkel, R., Eyck, D. V., Hanssens, L., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.855 · Cited by 314 · see citing works
Antipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
O'Keane, V., & Meaney, A. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150223.31007.e0 · Cited by 307 · see citing works
Olanzapine‐Associated Diabetes Mellitus
Koller, E. A., & Doraiswamy, P. M. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.11.841.33629 · Cited by 305 · see citing works
Premature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review
Roshanaei-Moghaddam, B., & Katon, W. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.147 · Cited by 305 · see citing works
Association between obesity and depression in middle-aged women
Simon, G. E., Ludman, E. J., Linde, J. A., Operskalski, B. H., Ichikawa, L., Rohde, P., Finch, E. A., & Jeffery, R. W. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.09.001 · Cited by 296 · see citing works
Regenold, W. T. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00456-6 · Cited by 293 · see citing works
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292 · see citing works
Cohn, T. A., Prud’homme, D., Streiner, D. L., Kameh, H., & Remington, G. J. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 290 · see citing works
Laurent, S. M., & Simons, A. D. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.06.007 · Cited by 288 · see citing works
Meyer, J. M., Davis, V. G., GOFF, D. C., McEvoy, J. P., Nasrallah, H. A., Thomas, S., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.487 · Cited by 286 · see citing works
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286 · see citing works
Mather, A. A., Cox, B. J., Enns, M. W., & Sareen, J. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.09.008 · Cited by 275 · see citing works
Smith, M. J., Hopkins, D., Peveler, R., Holt, R. I. G., Woodward, M., & Ismail, K. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037184 · Cited by 274 · see citing works
Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271 · see citing works
Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998
Lawrence, D. M., D'Arcy, C., Holman, J., Jablensky, A. V., & Hobbs, M. S. T. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.1.31 · Cited by 269 · see citing works
Falkai, P., Wobrock, T., Lieberman, J. A., Glenthoj, B. Y., Gattaz, W. F., Möller, H., & WFSBP Task Force on Treatment Guide (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 268 · see citing works
Self-citationFluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder
D, M. F. M., Judge, R., HOOG, S. L., Nilsson, M., & Koke, S. C. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1109 · Cited by 266 · see citing works
Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
Álvarez‐Jiménez, M., González‐Blanch, C., Crespo‐Facorro, B., Hetrick, S. E., Rodríguez-Sánchez, J. M., Pérez‐Iglesias, R., & Vázquez‐Barquero, J. L. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00002 · Cited by 266 · see citing works
Medical Risk in Patients With Bipolar Disorder and Schizophrenia
Newcomer, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.1106e16 · Cited by 264 · see citing works
Self-citationSexuality, pregnancy, and childrearing among women with schizophrenia- spectrum disorders
Miller, L. J., & Finnerty, M. T. (1996) · Psychiatric Services · doi:10.1176/ps.47.5.502 · Cited by 264 · see citing works
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261 · see citing works
HIV seroprevalence among people with severe mental illness in the United States: A critical review
Cournos, F., & McKinnon, K. (1997) · Clinical Psychology Review · doi:10.1016/s0272-7358(97)00018-4 · Cited by 261 · see citing works
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl, S. M., Mignon, L., & Meyer, J. M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01334.x · Cited by 258 · see citing works
Factors associated with the lumbar spine and proximal femur bone mineral density in older men
Cauley, J. A., Fullman, R. L., Stone, K. L., Zmuda, J. M., Bauer, D. C., Barrett-Connor, E., Ensrud, K., Lau, E. M. C., Orwoll, E. S., & For the Mr. OS Research Group (2005) · Osteoporosis International · doi:10.1007/s00198-005-1866-8 · Cited by 258 · see citing works
Sexual dysfunction in patients taking conventional antipsychotic medication
Smith, S., O'Keane, V., & Murray, R. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.1.49 · Cited by 256 · see citing works
Metabolic side effects of antipsychotic medication
Tschoner, A., Engl, J., Laimer, M. W., Kaser, S., Rettenbacher, M. A., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01416.x · Cited by 253 · see citing works
Depressive symptoms and occurrence of type 2 diabetes among Japanese men.
Kawakami, N., Takatsuka, N., Shimizu, H., & Ishibashi, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1071 · Cited by 253 · see citing works
Koller, E. A., Schneider, B., Bennett, K., & DUBITSKY, G. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01000-2 · Cited by 250 · see citing works
Binder, M. D., Schreurs, V., Sweers, K., Eyck, D. V., Hanssens, L., Šinko, S., Wampers, M., Scheen, A. J., Peuskens, J., & van Winkel, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.028 · Cited by 247 · see citing works
Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses
Carey, M. P., Carey, K. B., & Kalichman, S. C. (1997) · Clinical Psychology Review · doi:10.1016/s0272-7358(97)00019-6 · Cited by 246 · see citing works
The metabolic syndrome and schizophrenia
Meyer, J. M., & Stahl, S. M. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01317.x · Cited by 244 · see citing works
Carnethon, M. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg172 · Cited by 244 · see citing works
Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242 · see citing works
Mental disorders and quality of diabetes care in the veterans health administration.
Desai, M. M., Rosenheck, R., Druss, B., & Perlin, J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1584 · Cited by 238 · see citing works
Depressive Symptoms, Insulin Resistance, and Risk of Diabetes in Women at Midlife
Everson‐Rose, S. A., Meyer, P., Powell, L. H., Pandey, D. K., Torréns, J. I., Kravitz, H. M., Bromberger, J. T., & Matthews, K. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2856 · Cited by 237 · see citing works
Haematological toxicity of drugs used in psychiatry
Flanagan, R. J., & Dunk, L. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.917 · Cited by 236 · see citing works
Bipolar Disorder, Obesity, and Pharmacotherapy-Associated Weight Gain
Keck, P. E., & McElroy, S. L. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1205 · Cited by 234 · see citing works
Depressive Symptoms and the Risk of Type 2 Diabetes
Golden, S. H., Williams, J. E., Ford, D. E., Yeh, H., Sanford, C. P., Nieto, F. J., & Brancati, F. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.429 · Cited by 233 · see citing works
Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility
Every‐Palmer, S., McLean, R. M., Ellis, P. M., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0509 · Cited by 231 · see citing works
Hartemink, N., Boshuizen, H. C., Nagelkerke, N. J. D., Jacobs, M. A. M., & van Houwelingen, H. C. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj141 · Cited by 226 · see citing works
Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.006 · Cited by 223 · see citing works
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220 · see citing works
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
Witchel, H. J., Hancox, J. C., & Nutt, D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00010 · Cited by 219 · see citing works
Body Mass Index in Persons with Schizophrenia
Coodin, S. (2001) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674370104600610 · Cited by 217 · see citing works
The myth of the metabolic syndrome
Gale, E. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1873-5 · Cited by 217 · see citing works
Meaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217 · see citing works
Sudden death in psychiatric patients
Ruschena, D., Mullen, P. E., Burgess, P., Cordner, S., Barry-Walsh, J., Drummer, O., Palmer, S., Browne, C., & Wallace, C. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.4.331 · Cited by 217 · see citing works
Factors associated with risk for HIV infection among chronic mentally ill adults
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.221 · Cited by 216 · see citing works
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0408 · Cited by 216 · see citing works
Self-citationRisk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study
Hippisley-Cox, J., Vinogradova, Y., Coupland, C., & Parker, C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1368 · Cited by 214 · see citing works
Sexual dysfunction in male schizophrenic patients.
Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., & Weizman, A. (1995) · PubMed · Cited by 213 · see citing works
Bobes, J., A-PORTILLA, M. P. G., Rejas, J., ndez, G. H., García-García, M., Rico‐Villademoros, F., & PORRAS, A. (2003) · Journal of Sex & Marital Therapy · doi:10.1080/713847170 · Cited by 213 · see citing works
Self-citationPrevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
Bushe, C., & Holt, R. I. G. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.47.s67 · Cited by 212 · see citing works
Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis
Catts, V. S., Catts, S. V., O’Toole, B. I., & Frost, A. D. J. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01163.x · Cited by 209 · see citing works
Depressive Disorder, Dysthymia, and Risk of Stroke
Larson, S. L., Owens, P. L., Ford, D. E., & Eaton, W. W. (2001) · Stroke · doi:10.1161/hs0901.094623 · Cited by 208 · see citing works
Nielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207 · see citing works
Self-citationAntidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205 · see citing works
The effects of undertreated chronic medical illnesses in patients with severe mental disorders.
Fagiolini, A., & Goracci, A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7075su1c.04 · Cited by 205 · see citing works
Hert, M. A. F. D., van Winkel, R., Eyck, D. V., Hanssens, L. S., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-2-14 · Cited by 205 · see citing works
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204 · see citing works
Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications
Mcintyre, R., Konarski, J., Misener, V., & Kennedy, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590932380 · Cited by 203 · see citing works
Capasso, R., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & Sauver, J. L. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 201 · see citing works
Adiposity Compared With Physical Inactivity and Risk of Type 2 Diabetes in Women
Rana, J. S., Li, T. Y., Manson, J. E., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-1456 · Cited by 201 · see citing works
Flagged first, then by citations
Research works printed but not linked: 16
- Mental and Physical Health Platform., 2008, Mental and physical health charter. Bridging the gap between mental and physical health
- Parks J, 2006, Morbidity and mortality in people with serious mental illness
- Citrome L, 2007, Risk‐benefit analysis of available treatments for schizophrenia, Psychiatric Times, 1, 27
- Scheen A, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
- World Health Organization Department of Noncommunicable Disease Surveillance., 1999, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus
- Whiting D, 2010, Equity, social determinant and public health programmes, 77
- Department of Health., 2001, Diabetes national service framework
- Casey DE, 2004, Antipsychotic‐induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia, J Clin Psychiatry, 65, 4
- Nicol G, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32
- Pies RW, 2001, Antipsychotics: the heart of the problem, Psychiatric Times, 18, 26
- Lönnroth K, 2010, Equity, social determinants and public health programmes, 219
- Hammerschmidt S, 2009, Lung cancer: current diagnosis and treatment, Dtsch Arztebl Int, 106, 809
- Dupont A, 1986, Psychiatric case registries in public health, 229
- MalikP.Cross‐sectional study of bone density in patients with schizophrenic or schizophreniform disease.Dissertation Leopold‐Franzens University Innsbruck 2001.
- Montejo AL, 2001, Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients, J Clin Psychiatry, 62, 10
- Kwan S, 2010, Equity, social determinants and public health programmes, 159
Cited by
Sorted by citations
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115 · see citing works
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729 · see citing works
Self-citationVancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271 · see citing works
Self-citationMetabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145 · see citing works
Vancampfort, D., Firth, J., Schuch, F. B., Rosenbaum, S., Mugisha, J., Hallgren, M., Probst, M., Ward, P. B., Gaughran, F., De Hert, M., et al. (2017) · World Psychiatry · doi:10.1002/wps.20458 · Cited by 957 · see citing works
Self-citationDE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870 · see citing works
Self-citationCorrell, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820 · see citing works
Self-citationLawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819 · see citing works
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · see citing works
“[33] The European Psychiatric Association (EPA), the European Association for the Study of Diabetes (EASD) and European Society of Cardiology (ESC) have signed a common document with recommendations for monitoring markers of increased risk for metabolic syndrome and cardiovascular diseases.”
BackgroundClark, L. A., Cuthbert, B., Lewis-Fernández, R., Narrow, W. E., & Reed, G. M. (2017) · Psychological Science in the Public Interest · doi:10.1177/1529100617727266 · Cited by 688 · see citing works
Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659 · see citing works
Self-citationAlvares, G. A., Quintana, D. S., Hickie, I. B., & Guastella, A. J. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140217 · Cited by 503 · see citing works
Lawrance, E. L., Thompson, R., Newberry Le Vay, J., Page, L., & Jennings, N. (2022) · International Review of Psychiatry · doi:10.1080/09540261.2022.2128725 · Cited by 500 · see citing works
Measuring and improving the quality of mental health care: a global perspective
Kilbourne, A. M., Beck, K., Spaeth‐Rublee, B., Ramanuj, P., O'Brien, R. W., Tomoyasu, N., & Pincus, H. A. (2018) · World Psychiatry · doi:10.1002/wps.20482 · Cited by 457 · see citing works
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435 · see citing works
Self-citationCardiovascular disease in patients with severe mental illness
Nielsen, R. E., Banner, J., & Jensen, S. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00463-7 · Cited by 389 · see citing works
Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1314 · Cited by 384 · see citing works
The WPA-Lancet psychiatry commission on the future of psychiatry
Bhugra, D., Tasman, A., Pathare, S., Priebe, S., Smith, S., Torous, J., Arbuckle, M. R., Langford, A., Alarcón, R. D., Chiu, H. F. K., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30333-4 · Cited by 392 · see citing works
Alsubaie, M., Abbott, R., Dunn, B., Dickens, C., Keil, T. F., Henley, W., & Kuyken, W. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.04.008 · Cited by 383 · see citing works
An overview of links between obesity and mental health
Avila, C., Holloway, A. C., Hahn, M. K., Morrison, K. M., Restivo, M., Anglin, R., & Taylor, V. H. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0164-9 · Cited by 366 · see citing works
A systematic review and meta-analysis of premature mortality in bipolar affective disorder
Hayes, J. F., Miles, J., Walters, K., King, M., & Osborn, D. P. J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12408 · Cited by 370 · see citing works
Fernandes, B. S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J. A., Dean, O. M., Nardin, P., Gonçalves, C.-A., & Berk, M. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.87 · Cited by 348 · see citing works
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332 · see citing works
Self-citationReducing the stigma of mental health disorders with a focus on low- and middle-income countries
Javed, A., Lee, C., Zakaria, H., Buenaventura, R. D., Cetkovich-Bakmas, M., Duailibi, K., Ng, B., Ramy, H., Saha, G., Arifeen, S., et al. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102601 · Cited by 317 · see citing works
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324 · see citing works
Self-citationVancampfort, D., Correll, C. U., Wampers, M., Sienaert, P., Mitchell, A. J., De Herdt, A., Probst, M., Scheewe, T. W., & De Hert, M. (2014) · Psychological Medicine · doi:10.1017/s0033291713002778 · Cited by 317 · see citing works
Self-citationCooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292 · see citing works
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285 · see citing works
Self-citationCallaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255 · see citing works
Life expectancy at birth and all-cause mortality among people with personality disorder
Fok, M. L.-Y., Hayes, R. D., Chang, C.-K., Stewart, R., Callard, F. J., & Moran, P. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.05.001 · Cited by 241 · see citing works
Vermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P. J., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby052 · Cited by 246 · see citing works
Self-citationYouth Mental Health Should Be a Top Priority for Health Care in Canada
Malla, A., Shah, J., Iyer, S., Boksa, P., Joober, R., Andersson, N., Lal, S., & Fuhrer, R. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718758968 · Cited by 232 · see citing works
Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230 · see citing works
Vancampfort, D., Rosenbaum, S., Schuch, F. B., Ward, P. B., Probst, M., & Stubbs, B. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.11.008 · Cited by 225 · see citing works
Mental health research priorities for Europe
Wykes, T., Haro, J. M., Belli, S. R., Obradors-Tarragó, C., Arango, C., Ayuso-Mateos, J. L., Bitter, I., Brunn, M., Chevreul, K., Demotes-Mainard, J., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00332-6 · Cited by 218 · see citing works
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
Barton, B. B., Segger, F., Fischer, K., Obermeier, M., & Musil, R. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1713091 · Cited by 216 · see citing works
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214 · see citing works
Osborn, D. P. J., Hardoon, S., Omar, R. Z., Holt, R. I. G., King, M., Larsen, J., Marston, L., Morris, R. W., Nazareth, I., Walters, K., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2133 · Cited by 200 · see citing works
Björkenstam, E., Ljung, R., Burström, B., Mittendorfer-Rutz, E., Hallqvist, J., & Weitoft, G. R. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000778 · Cited by 190 · see citing works
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186 · see citing works
Murphy, J., Brewer, R., Hobson, H., Catmur, C., & Bird, G. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.05.010 · Cited by 180 · see citing works
Caemmerer, J., Correll, C. U., & Maayan, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.017 · Cited by 182 · see citing works
Vancampfort, D., Probst, M., Scheewe, T., De Herdt, A., Sweers, K., Knapen, J., van Winkel, R., & De Hert, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.026 · Cited by 173 · see citing works
Self-citationComorbid medical illness in bipolar disorder
Forty, L., Ulanova, A., Jones, L., Jones, I., Gordon-Smith, K., Fraser, C., Farmer, A., McGuffin, P., Lewis, C. M., Hosang, G. M., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152249 · Cited by 166 · see citing works
Vistorte, A. O. R., Ribeiro, W. S., Jaen, D., Jorge, M. R., Evans-Lacko, S., & Mari, J. D. J. (2018) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217418778620 · Cited by 160 · see citing works
ROAMER: roadmap for mental health research in Europe
Haro, J. M., Ayuso‐Mateos, J. L., Bitter, I., Demotes‐Mainard, J., Leboyer, M., Lewis, S. W., Linszen, D., Maj, M., Mcdaid, D., Meyer‐Lindenberg, A., et al. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1406 · Cited by 163 · see citing works
Vancampfort, D., Firth, J., Schuch, F., Rosenbaum, S., De Hert, M., Mugisha, J., Probst, M., & Stubbs, B. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.020 · Cited by 159 · see citing works
Self-citationAssociations between sedentary behaviour and metabolic parameters in patients with schizophrenia
Vancampfort, D., Probst, M., Knapen, J., Carraro, A., & De Hert, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.046 · Cited by 149 · see citing works
Stubbs, B., Thompson, T., Acaster, S., Vancampfort, D., Gaughran, F., & Correll, C. U. (2015) · Pain · doi:10.1097/j.pain.0000000000000304 · Cited by 141 · see citing works
Self-citationVancampfort, D., Probst, M., Helvik Skjaerven, L., Catalán-Matamoros, D., Lundvik-Gyllensten, A., Gómez-Conesa, A., Ijntema, R., & De Hert, M. (2012) · Physical Therapy · doi:10.2522/ptj.20110218 · Cited by 141 · see citing works
Self-citationGardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000562 · Cited by 140 · see citing works
Smith, D. J., Martin, D., McLean, G., Langan, J., Guthrie, B., & Mercer, S. W. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-263 · Cited by 138 · see citing works
Rajkumar, A. P., Horsdal, H. T., Wimberley, T., Cohen, D., Mors, O., Børglum, A. D., & Gasse, C. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16040442 · Cited by 137 · see citing works
Self-citationFarahani, A., & Correll, C. U. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07324 · Cited by 131 · see citing works
Self-citationThe prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis
Stubbs, B., Eggermont, L., Mitchell, A. J., De Hert, M., Correll, C. U., Soundy, A., Rosenbaum, S., & Vancampfort, D. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12325 · Cited by 129 · see citing works
Fortuna, K. L., DiMilia, P. R., Lohman, M. C., Bruce, M. L., Zubritsky, C. D., Halaby, M. R., Walker, R. M., Brooks, J. M., & Bartels, S. J. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-017-9534-7 · Cited by 109 · see citing works
Avoidable mortality in people with schizophrenia or bipolar disorder in <scp>E</scp>ngland
Hoang, U., Goldacre, M. J., & Stewart, R. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12045 · Cited by 109 · see citing works
Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., van Amelsvoort, T., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.007 · Cited by 104 · see citing works
Self-citationStubbs, B., Vancampfort, D., Veronese, N., Thompson, T., Fornaro, M., Schofield, P., Solmi, M., Mugisha, J., Carvalho, A. F., & Koyanagi, A. (2017) · Psychological Medicine · doi:10.1017/s0033291717001477 · Cited by 102 · see citing works
Stubbs, B., Mitchell, A. J., De Hert, M., Correll, C. U., Soundy, A., Stroobants, M., & Vancampfort, D. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.017 · Cited by 92 · see citing works
Self-citationSudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients
Ifteni, P., Correll, C. U., Burtea, V., Kane, J. M., & Manu, P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.011 · Cited by 91 · see citing works
Self-citationBarriers to Self-management of Serious Mental Illness and Diabetes
Blixen, C. E., Kanuch, S., Perzynski, A. T., Thomas, C., Dawson, N. V., & Sajatovic, M. (2016) · American Journal of Health Behavior · doi:10.5993/ajhb.40.2.4 · Cited by 90 · see citing works
Mindfulness-based stress reduction for long-term physical conditions: a systematic review.
Crowe, M., Jordan, J., Burrell, B., Jones, V., Gillon, D., & Harris, S. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415607984 · Cited by 85 · see citing works
Yu, Q., Wong, K.-K., Lei, O.-K., Nie, J., Shi, Q., Zou, L., & Kong, Z. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00529-5 · Cited by 80 · see citing works
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79 · see citing works
Gates, J., Killackey, E., Phillips, L., & Álvarez-Jiménez, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00213-8 · Cited by 72 · see citing works
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73 · see citing works
Barriers to effective diabetes management–a survey of people with severe mental illness
Mulligan, K., McBain, H., Lamontagne-Godwin, F., Chapman, J., Flood, C., Haddad, M., Jones, J., & Simpson, A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1744-5 · Cited by 68 · see citing works
Positive mental health and mental health stigma: A qualitative study assessing student attitudes
Vidourek, R. A., & Burbage, M. (2019) · Mental Health & Prevention · doi:10.1016/j.mhp.2018.11.006 · Cited by 67 · see citing works
Melo, A. P. S., Dippenaar, I. N., Johnson, S. C., Weaver, N. D., de Assis Acurcio, F., Malta, D. C., Ribeiro, A. L. P., Júnior, A. A. G., Wool, E. E., Naghavi, M., et al. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00237-1 · Cited by 66 · see citing works
Zivkovic, S., Koh, C. H., Kaza, N., & Jackson, C. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2177-5 · Cited by 65 · see citing works
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder
Grootens, K. P., Meijer, A., Hartong, E. G., Doornbos, B., Bakker, P. R., Al Hadithy, A., Hoogerheide, K. N., Overmeire, F., Marijnissen, R. M., & Ruhe, H. G. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2517-2 · Cited by 60 · see citing works
Perry, A., Lawrence, V., & Henderson, C. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.112974 · Cited by 51 · see citing works
Insufficient Dollars and Qualified Personnel to Meet United States Mental Health Needs
Weil, T. P. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000271 · Cited by 50 · see citing works
Pauselli, L., Verdolini, N., Bernardini, F., Compton, M. T., & Quartesan, R. (2017) · Psychiatric Quarterly · doi:10.1007/s11126-016-9440-4 · Cited by 49 · see citing works
De Hert, M., Van Bos, L., Sweers, K., Wampers, M., De Lepeleire, J., & Correll, C. U. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144749 · Cited by 44 · see citing works
Self-citationAngdembe, M., Kohrt, B. A., Jordans, M., Rimal, D., & Luitel, N. P. (2017) · International Journal of Mental Health Systems · doi:10.1186/s13033-017-0176-9 · Cited by 39 · see citing works
Ayano, G., Tulu, M., Haile, K., Assefa, D., Habtamu, Y., Araya, G., & Yohannis, Z. (2018) · Annals of General Psychiatry · doi:10.1186/s12991-018-0186-2 · Cited by 37 · see citing works
Diabetes, physical activity participation and exercise capacity in patients with schizophrenia
Vancampfort, D., De Hert, M., Sweers, K., De Herdt, A., Detraux, J., & Probst, M. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12077 · Cited by 34 · see citing works
Self-citationPain management in people with severe mental illness: an agenda for progress
Onwumere, J., Stubbs, B., Stirling, M., Shiers, D., Gaughran, F., Rice, A. S. C., C de C Williams, A., & Scott, W. (2022) · Pain · doi:10.1097/j.pain.0000000000002633 · Cited by 35 · see citing works
Increased inflammasome activity in markedly ill psychiatric patients: an explorative study
Hylén, U., Eklund, D., Humble, M., Bartoszek, J., Särndahl, E., & Bejerot, S. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577119 · Cited by 32 · see citing works
Carneiro, L., Afonso, J., Ramirez-Campillo, R., Murawska-Ciałowciz, E., Marques, A., & Clemente, F. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186715 · Cited by 31 · see citing works
Young, S. J., Praskova, A., Hayward, N., & Patterson, S. (2017) · Health & Social Care in the Community · doi:10.1111/hsc.12349 · Cited by 31 · see citing works
Emotion dysregulation as a cross-cutting target for inpatient psychiatric intervention
Fowler, J. C., Clapp, J. D., Madan, A., Allen, J. G., Oldham, J. M., & Frueh, B. C. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.043 · Cited by 29 · see citing works
How meaningful activities influence the recovery process
Nordaunet, O. M., & Sælør, K. T. (2018) · Advances in Dual Diagnosis · doi:10.1108/add-01-2018-0002 · Cited by 30 · see citing works
Lambert, M., Ruppelt, F., Siem, A.-K., Rohenkohl, A. C., Kraft, V., Luedecke, D., Sengutta, M., Schröter, R., Daubmann, A., Correll, C. U., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.036 · Cited by 29 · see citing works
Korman, N., Fox, H., Skinner, T., Dodd, C., Suetani, S., Chapman, J., Parker, S., Dark, F., Collins, C., Rosenbaum, S., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00319 · Cited by 27 · see citing works
Speyer, H., Nørgaard, H. C. B., Hjorthøj, C., Madsen, T. A., Drivsholm, S., Pisinger, C., Gluud, C., Mors, O., Krogh, J., & Nordentoft, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0465-2 · Cited by 20 · see citing works
Integrated Care for Older Adults with Serious Mental Illness and Medical Comorbidity
Bartels, S. J., DiMilia, P. R., Fortuna, K. L., & Naslund, J. A. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.11.012 · Cited by 20 · see citing works
Burian, H., Böge, K., Burian, R., Burns, A., Nguyen, M. H., Ohse, L., Ta, T. M. T., Hahn, E., & Diefenbacher, A. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110374 · Cited by 19 · see citing works
Fortuna, K. L., Lebby, S., Geiger, P., Johnson, D., MacDonald, S., Chefetz, I., Ferron, J. C., St George, L., Rossom, R., Kalisa, J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.15479 · Cited by 18 · see citing works
Psychiatric aspects of infectious diseases
Mufaddel, A., Omer, A. A., & Salem, M. O. (2014) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2014.43027 · Cited by 14 · see citing works
Preventive service use among people with and without serious mental illnesses.
Yarborough, B. J. H., Perrin, N. A., Stumbo, S. P., Muench, J., & Green, C. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.08.020 · Cited by 13 · see citing works
Perez, T. M., Glue, P., Adhia, D. B., Navid, M. S., Zeng, J., Dillingham, P., Smith, M., Niazi, I. K., Young, C. K., & De Ridder, D. (2022) · Trials · doi:10.1186/s13063-022-06863-z · Cited by 8 · see citing works
“This has significant clinical implications considering that cardiovascular disease is the leading cause of mortality in people with mental illness [52, 294, 295].”
BackgroundEpidemiologische Beiträge zur Klinischen Psychologie
Beesdo-Baum, K., Höfler, M., Jacobi, F., & Wittchen, H.-U. (2020) · Klinische Psychologie & Psychotherapie · doi:10.1007/978-3-662-61814-1_3 · Cited by 6 · see citing works
Gulliver, A., Morse, A. R., Wilson, N., Sargent, G., & Banfield, M. (2018) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2018.03.001 · Cited by 6 · see citing works
Chronic pain management group psychotherapy for psychiatric inpatients: A pilot study
Osborne, P. J., Jimenez-Torres, G. J., Landa, Y., Mahoney, J., & Madan, A. (2017) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2017.81.2.123 · Cited by 5 · see citing works
Orme, W. H., Fowler, J. C., Bradshaw, M. R., Carlson, M., Hadden, J., Daniel, J., Flack, J. N., Freeland, D., Head, J., Marder, K., et al. (2022) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000623 · Cited by 2 · see citing works
De, R., Amin Alfatwa, Y., Kanagasundaram, P., Saragosa, J. E., Chan, J., Remington, G., Retnakaran, R., Sanches, M., Sockalingam, S., Agarwal, S. M., et al. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf236 · Cited by 1 · see citing works
“7 – 9 Obesity remains an important cardiometabolic risk factor in SMI not only due to lifestyle factors ranging from an unhealthy diet and behaviors to a lack of physical activity, 10 but also owing to metabolic dysregulation associated with antipsychotic treatments.”
- Authors
- DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., & LEUCHT, S.
- Affiliations
- Albert Einstein College of Medicine (US)
- Universidad de Oviedo (ES)
- University of Groningen (NL)
- KU Leuven (BE)
- SMS Medical College (IN)
- University of Nairobi (KE)
- Washington University in St. Louis (US)
- Nnamdi Azikiwe University (NG)
- Technical University of Munich (DE)
- ORCID
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2011-02
- Volume
- 10
- Issue
- 1
- Pages
- 52-77
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- PMC
- PMC3048500
- OpenAlex
- W2116251861
- Semantic Scholar
- 611c371ce31e6dedc3d58ef6f711b7a21edbc450
- Cited by
- 2,488
- References
- 605
- Citations by year
- 2026: 119 · 2025: 142 · 2024: 159 · 2023: 174 · 2022: 209 · 2021: 190 · 2020: 224 · 2019: 181 · 2018: 171 · 2017: 162 · 2016: 186 · 2015: 147 · 2014: 112 · 2013: 216 · 2012: 68
- FWCI
- 93.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- World Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Nairobi Research Archive (University of Nairobi) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- American Heart Association
- Bristol-Myers Squibb
- Pfizer
- Società Italiana di Psichiatria Biologica
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- severe mental illness, physical illness, comorbidities, excess mortality, psychotropic medication side effects, health care disparities, lifestyle factors, cardiovascular disease, obesity, sexual dysfunction, screening, schizophrenia, bipolar disorder, major depressive disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review